2026 Annual Meeting | P3 - Poster Session 03

Date Sunday 04/19/26

Time 05:00 PM - 06:00 PM CDT Add To Calendar

Location McCormick Place West | Hall F

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Neuro-oncology, Sleep, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Neuro-rehabilitation, Education, Research, and Methodology, Autoimmune Neurology, Neuro Trauma and Critical Care, Pain

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:00 PM - 06:00 PM CDT	Abstract	15-001 - A Newly Developed Neurology Clerkship Leads to Increased Match Rates into Neurology at Texas A&M College of Medicine Maya M. Ramy, MD
05:00 PM - 06:00 PM CDT	Abstract	15-002 - Implementation of the Student Neurology Ambulatory Preceptorship Matthew S. Robbins, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	15-003 - Conservative Management of Neurophobia – Evaluation of Effective Ways to Minimize the Fear of Neurology in Clinical Stages of Medical Education Olga R. Thon, MD
05:00 PM - 06:00 PM CDT	Abstract	15-004 - Mapping Neurology Elective Opportunities for Medical Students in the United States Chinmayi Balusu, MPH
05:00 PM - 06:00 PM CDT	Abstract	15-005 - Neurology for Medical Students by Medical Students: Analysis of the NeuroBytes Medical Student Series Allison M. LeHanka
05:00 PM - 06:00 PM CDT	Abstract	15-006 - Aquifer Neurology: An Online Peer-reviewed Case-based Neurology Curriculum for Health Professions Students Stefanie Cappucci, MD
05:00 PM - 06:00 PM CDT	Abstract	15-007 - Mind Over Manuscript: Impact of a Medical Student-Led Neurology Journal Club Audrey Huang
05:00 PM - 06:00 PM CDT	Abstract	15-008 - A Universe Inside the Skull Habib E. Akouri
05:00 PM - 06:00 PM CDT	Abstract	15-009 - Gamifying Stroke Education: A Resident/Faculty-led Interactive Model for Early Neurology Engagement of Medical Students Avi Singh Gandh, MD
05:00 PM - 06:00 PM CDT	Abstract	15-010 - Flipped Classroom Flips Scores: Integrating Online Learning to Improve Medical Student Curriculum Ana C. Felix, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	15-011 - Evaluating a Longitudinal Neurology Rotation to Enhance Medical Student Engagement Karishma A. Popli, MD, MBE
05:00 PM - 06:00 PM CDT	Abstract	15-012 - Addressing Neurophobia in Ghana: Effects of an AAN SIGN Chapter on Medical Student Perceptions. CARL A. HASFORD, MD
05:00 PM - 06:00 PM CDT	Abstract	15-013 - Desensitization Protocol in Patients with Immediate Eptinezumab Hypersensitivity: A Case Series Aimen Vanood, MD
05:00 PM - 06:00 PM CDT	Abstract	15-014 - Prevalence of Headache and its impacts on Academic and Social lives Among University Students in Egypt: A Cross-Sectional Study Samar Shehata
05:00 PM - 06:00 PM CDT	Abstract	15-015 - Elevated Peak Width of Skeletonized Mean Diffusivity Indicates a Transient Disease-like White Matter State in Status Migrainosus Jennifer V. Robblee, MD
05:00 PM - 06:00 PM CDT	Abstract	15-016 - Plasma Metabolite Signature for Migraine Pamela Rist, PhD
05:00 PM - 06:00 PM CDT	Abstract	15-017 - Associations Between Cortical Morphometry and Clinical Parameters in Migraine: 112-Patient Observational Study Noboru Imai
05:00 PM - 06:00 PM CDT	Abstract	15-018 - Delayed Onset, Fully Reversible Changes on Brain MRI in Prolonged Migraine Aura Roaa Zayat, MD
05:00 PM - 06:00 PM CDT	Abstract	15-019 - Serial Vibration Sensory Deficits and Recovery in Children and Teenagers with Migraines Charles E. Niesen, MD
05:00 PM - 06:00 PM CDT	Abstract	15-020 - Cortical Excitability Changes and Precipitation/Resolution of Migraine Attacks: A Study with Sound Induced Flash Illusions (SIFI) Filippo Brighina, MD
05:00 PM - 06:00 PM CDT	Abstract	9-001 - Fibular Mononeuropathy From Weight Loss Associated With GLP-1 Receptor Agonist Use Jacob Farris, MD
05:00 PM - 06:00 PM CDT	Abstract	9-002 - A Rare Case of Severe Sensory Ganglionopathy in a Patient With a Thymoma Sanjana Nayak, MD
05:00 PM - 06:00 PM CDT	Abstract	9-003 - Sensory Ganglionopathy Progressing to Severe Dysphagia and Disability Eileen Yung, MD
05:00 PM - 06:00 PM CDT	Abstract	9-004 - Significant Sensorimotor Polyneuropathy Caused by Dry Beriberi Secondary to Semaglutide-associated Thiamine Deficiency Chloe J. Cohan
05:00 PM - 06:00 PM CDT	Abstract	9-005 - Early-onset Hereditary Spastic Paraplegia (SPG3A) Misdiagnosed as Diplegic Cerebral Palsy in a Child With Multigenerational Family History and Normal Birth Ahmed A. Mohamed, MD
05:00 PM - 06:00 PM CDT	Abstract	9-006 - My Zebra for Your Horses: A Unique Case of Respiratory Failure in the Setting of Delayed Diagnosis of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Kennedy Gerber
05:00 PM - 06:00 PM CDT	Abstract	9-007 - Cerebellar Syndrome Associated With a Pathogenic SOD1 Variant: A Case Report Fatma Yesim Parman, MD
05:00 PM - 06:00 PM CDT	Abstract	9-008 - Distal Agrin (AGRN) Congenital Myasthenic Syndrome With Mitochondrial Dysfunction Mariana Hiromi M. Oku, MD
05:00 PM - 06:00 PM CDT	Abstract	9-009 - Severe Transient Neonatal Myasthenia Gravis in a Late Preterm Infant: Diagnostic and Management Challenges Naman D. Shah, MD
05:00 PM - 06:00 PM CDT	Abstract	9-011 - Fasciculations Secondary to Severe Vitamin B12 Deficiency Mimicking Motor Neuron Disease Manmeet P. Kaur, MD
05:00 PM - 06:00 PM CDT	Abstract	9-012 - Recognizing Amyotrophic Lateral Sclerosis Early: Bilateral Internal Capsule Hyperintensities as a Diagnostic Clue Christopher Gilbert, MD
05:00 PM - 06:00 PM CDT	Abstract	9-013 - Mitochondrial Trifunctional Protein Deficiency Masquerading as Charcot-Marie-Tooth Disease Arman Cakar
05:00 PM - 06:00 PM CDT	Abstract	9-014 - A PNPLA6 Variant Case Report With a Combination of Heterozygous Mutations Lisle W. Blackbourn IV, MD
05:00 PM - 06:00 PM CDT	Abstract	9-015 - Rare Case of Hereditary Transthyretin Amyloidosis With a Val122Ile Mutation Presenting as Recurrent Foot Drop in a Young Woman Hanna Malik, DO
05:00 PM - 06:00 PM CDT	Abstract	9-016 - Young-Adulthood Onset Chronic Cough as a Three Decades Prodrome of RFC1-related Autonomic and Sensory Neuropathy Kyle R. Marden, MD
05:00 PM - 06:00 PM CDT	Abstract	9-017 - Hereditary Myopathy With Early Respiratory Failure, Mimicking CIDP: Diagnostic Challenges With Atypical Presentations Minna Choi, MD
05:00 PM - 06:00 PM CDT	Abstract	3-001 - Amitriptyline for Acute Mild Traumatic Brain Injury (mTBI) Ava Panetto
05:00 PM - 06:00 PM CDT	Abstract	3-002 - Serum Dynamics of BD-Tau, NF-L, GFAP, UCH-L1, p-Tau181, and S100B as Diagnostic Biomarkers in Concussion and Mild Traumatic Brain Injury Ahmed Chenna, PhD
05:00 PM - 06:00 PM CDT	Abstract	3-003 - Characterizing Patients on Memantine and Their Response to Treatment for Post Traumatic Headache Bradley Shane, MD
05:00 PM - 06:00 PM CDT	Abstract	3-004 - Efficacy of Methylprednisolone Taper in Treating Posttraumatic Headache Glynnis Zieman, MD, MPH, FAAN
05:00 PM - 06:00 PM CDT	Abstract	3-005 - Exploring the Role of Angiotensin Receptor Blockers in the Management of Traumatic Brain Injury: A Review of Mechanisms and Therapeutic Potential Manaal Salman
05:00 PM - 06:00 PM CDT	Abstract	3-007 - Subjective and Objective Findings of Anosmia are Discordant and Persist for Six Months in Hospitalized Individuals With Traumatic Brain Injury Trevor McCutcheon
05:00 PM - 06:00 PM CDT	Abstract	3-008 - Optimal Amantadine Dosing Strategy for Neurological and Functional Recovery in Traumatic Brain Injury: A Network-metanalysis Pavan Raju Kola, MD
05:00 PM - 06:00 PM CDT	Abstract	3-009 - Early Exercise Response as a Prognostic Tool for Recovery Time in Sport-related Concussion Amir Mashni
05:00 PM - 06:00 PM CDT	Abstract	3-010 - Traumatic Cerebrospinal Fluid Leak Following Repetitive Back Impacts During Wrestling Training: An Atypical Case Presentation Krima Patel, DO
05:00 PM - 06:00 PM CDT	Abstract	3-011 - Safety, Efficacy and Pharmacokinetics of HS-10506 in the Insomnia Patients: A Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Study YuPing Wang, PhD
05:00 PM - 06:00 PM CDT	Abstract	3-013 - Neuroprotective Potential of Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Retrospective Cohort Study Using TriNetX Aayma Irfan, Medical Student
05:00 PM - 06:00 PM CDT	Abstract	3-014 - Neurofilament Light Chain Trajectory Predicts Survival in ALS: Validation Across Independent Cohorts Benjamin M. Greenberg, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	12-001 - New Temporal Lobe Connections Underlying Single Word Comprehension and Reading Salvatore Citro, MD
05:00 PM - 06:00 PM CDT	Abstract	12-002 - Structural Evolution of the Frontal Aslant Tract: Implications for Primate Vocalization and Human Speech Salvatore Citro, MD
05:00 PM - 06:00 PM CDT	Abstract	12-003 - Mapping Distorted Faces: Lesion-phenotype Alignment and AI-based Visualization in Prosopometamorphopsia (1947-2025) Shweta Kalita, MD
05:00 PM - 06:00 PM CDT	Abstract	12-004 - Characterization of Novel Mouse Models of Microglial Conditional Knockout of L-type Calcium Channel Cav1.2 and Cav1.3 Subtypes Rachael K. Cundey
05:00 PM - 06:00 PM CDT	Abstract	12-005 - Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans Yanghong Yang, MD
05:00 PM - 06:00 PM CDT	Abstract	12-006 - The Effect of Menopause and Metabolic Disease on Neurogenesis in an AD Mouse Model Aaron Paul
05:00 PM - 06:00 PM CDT	Abstract	12-007 - Task Goals Reorganize Visual Codes in Human Ventral Temporal Cortex via Medial Frontal Modulation Robert Kim, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	12-008 - Whole-brain and Default Mode Network Modularity Vary with Reproductive Lifecycle Variables Jordan Galbraith
05:00 PM - 06:00 PM CDT	Abstract	12-009 - Correction of Age-dependent Mitochondrial Dysfunction via Autophagy Enhancement in Reprogrammed Human Neurons Eva Klinman, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	12-010 - Leveraging MHConstructor to Uncover Structural Variation in the MHC in Alzheimer’s Disease Ilaria Stewart
05:00 PM - 06:00 PM CDT	Abstract	12-011 - Effects of Systemic Inflammation on Neuronal Activity of Transgenic Alzheimer's Mice Using c-Fos Mapping Tommy Kim
05:00 PM - 06:00 PM CDT	Abstract	12-012 - Cross-modality Transformation from SWI to QSM Based on U-net Gan Xingqi Pan
05:00 PM - 06:00 PM CDT	Abstract	12-013 - When Sleep Fails the Brain: Exploring Early Alzheimer’s Changes in Young and Midlife Adults Saad Tanzeem
05:00 PM - 06:00 PM CDT	Abstract	12-014 - CNS Drugs Targeting the Neuropsychiatric and Cognitive Symptoms of Alzheimer’s Disease Aidan R. Butler
05:00 PM - 06:00 PM CDT	Abstract	12-015 - A Cross-sectional Analysis of Alzheimer’s Information on TikTok: Investigating the Role of Healthcare Professionals in Social Media Data Abdullah Obadi, MD
05:00 PM - 06:00 PM CDT	Abstract	6-001 - Clinical Efficacy of Immune Checkpoint Inhibitors in Glioblastoma and Brain Metastases Maria Fioletova
05:00 PM - 06:00 PM CDT	Abstract	6-002 - Ictal–interictal Continuum and Inflammatory Encephalopathy as the Initial Presentation of CNS Hemophagocytic Lymphohistiocytosis Nishel Y. Kothari, MBBS
05:00 PM - 06:00 PM CDT	Abstract	6-003 - Multiple, Simultaneous, Severe Neurological Complications of ATRA and ATO During Acute Promyelocytic Leukemia Treatment: A Case Report Arth Pahwa, MD, MBA
05:00 PM - 06:00 PM CDT	Abstract	6-004 - Seizure Characteristics Differ Among Grade Four Glioma Subtypes Lydia Guo
05:00 PM - 06:00 PM CDT	Abstract	6-005 - Serious Illness Conversation Documentation in High-grade Glioma Caroline Crooms, MD, MPH
05:00 PM - 06:00 PM CDT	Abstract	6-006 - Nutrition and its Impact on Quality of Life in Patients With Brain Tumors: A Scoping Review Jude Banihani, MD
05:00 PM - 06:00 PM CDT	Abstract	6-007 - The Survival Outcomes of Patients With NF1 Associated High-grade Glioma Treated With MEK Inhibitors Tracy Ming-Chun Yu, MD
05:00 PM - 06:00 PM CDT	Abstract	6-008 - Variability in MRI Surveillance of Sporadic Vestibular Schwannomas: A Scoping Review to Guide Optimization Brian Ellis
05:00 PM - 06:00 PM CDT	Abstract	6-009 - Development of Molecular and Quantitative Spatiotemporal Modeling of Physics Informed Neural Network (PINN) with in Vitro-Driven Validation Modeling for Blood-Tumor Barrier Transport, Resistance Dynamics, and Therapeutic Penetration Mechanisms in Patient-Specific Glioblastoma Surgery Shivi Kumar
05:00 PM - 06:00 PM CDT	Abstract	6-010 - A Comparative Study of Large Vision-Language Models for Retinal Image-Based Alzheimer’s Disease Identification Vincent Wang
05:00 PM - 06:00 PM CDT	Abstract	6-011 - Suppression of Immune Response to Brain Implants Using Antibody SIF001 Against Galectin-3, a Key Player in Inflammation Joseph Sun
05:00 PM - 06:00 PM CDT	Abstract	7-001 - Case Report: Diagnostic Challenges and Atypical MRI Findings in Two Cases of Creutzfeldt-Jakob Disease Ayesha Syed
05:00 PM - 06:00 PM CDT	Abstract	7-002 - Dermato-neuro Syndrome Following Intravenous Immunoglobulin Infusion: A Case Report Bryce Kassalow, BA
05:00 PM - 06:00 PM CDT	Abstract	7-003 - Fluctuating Weakness with Hyperthyroidism: A Case Report Chen Chen, MD
05:00 PM - 06:00 PM CDT	Abstract	7-004 - Methylmalonic Aciduria in Adulthood: A Case Report David Benhuri, MD
05:00 PM - 06:00 PM CDT	Abstract	7-005 - Spinal Epidural Lipomatosis (SEL): Two Case Reports Highlighting Underrecognized Mimics of Neuroinflammatory Disease and Degenerative Spinal Stenosis Respectively — A Note for Neurologists Yu Cai
05:00 PM - 06:00 PM CDT	Abstract	7-006 - Case Report: Infantile Onset with Adult Presentation of Alexander disease Kole Sedlack, MD
05:00 PM - 06:00 PM CDT	Abstract	7-007 - A Case Report on Post Radiotherapy Recurrence of Brainstem Glioma Symptoms Mansoor Iqbal
05:00 PM - 06:00 PM CDT	Abstract	7-008 - Adult-onset Bethlem Myopathy Masquerading as a Demyelinating Disorder: A Case Report from Puerto Rico Ricardo E. Calderón Rivera, BS
05:00 PM - 06:00 PM CDT	Abstract	7-009 - Copper Deficiency Myelopathy As A Nutritional Complication of GLP-1/GIP Receptor Agonist Therapy: A Case Report Clay V. Willis
05:00 PM - 06:00 PM CDT	Abstract	7-010 - Concurrent Intracranial Hypotension and Hypertension in a Patient with Refractory CSF Leak: A Case Report Pranshi Juneja, DO
05:00 PM - 06:00 PM CDT	Abstract	7-011 - CHANTER Syndrome: A Case Report of a Recently Described Toxidrome in a 72-year-old Male Amanda Jarosik
05:00 PM - 06:00 PM CDT	Abstract	7-012 - Dyke-Davidoff-Masson Syndrome in an Adult with Pulmonary Tuberculosis; Diagnostic Challenges and Management Considerations: A Rare Case Report and Literature Review Muhammad Moiz Javed, MD
05:00 PM - 06:00 PM CDT	Abstract	7-013 - Spontaneous Cerebrospinal Fluid Rhinorrhea Secondary to Idiopathic Intracranial Hypertension: A Rare Case Report and Review of Literature Muhammad Moiz Javed, MD
05:00 PM - 06:00 PM CDT	Abstract	7-014 - Navigating a Rare CNS Inflammatory Syndrome: Case Report of CLIPPERS with Classic MRI Features and Steroid Responsiveness Ramsha Siddiqui, MBBS
05:00 PM - 06:00 PM CDT	Abstract	1-001 - A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab to Prevent Relapses in Neuromyelitis Optica Spectrum Disorder (NMOSD) Michael Levy, MD, PhD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	1-002 - Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention Andreu Vilaseca-Jolonch, MD
05:00 PM - 06:00 PM CDT	Abstract	1-003 - Serum Proteomics Reveals Altered Pathways in Double-negative Neuromyelitis Optica Spectrum Disorder Beyza Canik, MD
05:00 PM - 06:00 PM CDT	Abstract	1-004 - The Role of SATB1 and the Treg/Th17 Cell Balance in Neuromyelitis Optica Spectrum Disorders Hongbo Liu
05:00 PM - 06:00 PM CDT	Abstract	1-005 - Seasonality of Initial Attack Onset in AQP4+ NMOSD, MOGAD, and MS: Observations from a US-based Multicenter Cohort Shuvro Roy, MD
05:00 PM - 06:00 PM CDT	Abstract	1-006 - A Real-world Study of the Effectiveness and Safety of Ravulizumab in AQP4-Ab+ NMOSD Patients with Suboptimal Response to Satralizumab in Japan - Interim Analysis Sami Fam
05:00 PM - 06:00 PM CDT	Abstract	1-007 - Financial and Mental Health Burden on Caregivers of Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States Evanthia Bernitsas, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	1-008 - Bilateral Optic Neuritis in MOGAD: Treatment Patterns and Relapse Outcomes Tony Alocious
05:00 PM - 06:00 PM CDT	Abstract	1-009 - Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series Eoin P. Flanagan, MBBCh, FAAN
05:00 PM - 06:00 PM CDT	Abstract	1-010 - Efficacy and Safety of Plasma Exchange in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease in Adults: A Systematic Review and Meta-analysis Marina Vilardo
05:00 PM - 06:00 PM CDT	Abstract	1-011 - NMOSD Treatment Patterns in the Era of Approved Biologics: An Analysis from the SPHERES Registry Michael Levy, MD, PhD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	1-012 - Inebilizumab for Treatment of NMOSD in a Real-world Cohort: Analysis from the SPHERES Registry Michael Levy, MD, PhD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	18-001 - Social Determinants of Health Regarding Hospitalization and Comorbidities in a Nationally Representative Inpatient Sample of Individuals With and Without Multiple Sclerosis Aneesh Kamath
05:00 PM - 06:00 PM CDT	Abstract	18-002 - A Retrospective Analysis of Factors Contributing to Delayed or Missed Treatment With Ocrelizumab in Patients With Multiple Sclerosis Lana Sharba, MD
05:00 PM - 06:00 PM CDT	Abstract	18-003 - Childhood Adversity is Associated With Greater MS Symptoms, Disability Scores, and Epigenetic Changes in Pediatric and Adult-onset Multiple Sclerosis Kimberly O'Neill, MD
05:00 PM - 06:00 PM CDT	Abstract	18-004 - Disparities and Outcomes in Multiple Sclerosis Hospitalizations Complicated by Substance Use Disorder: A Seven-year Nationwide Analysis Hafiz M. Maaz
05:00 PM - 06:00 PM CDT	Abstract	18-005 - Exploring the Influence of Health Determinants on Perceived Social Support in Patients With Multiple Sclerosis Arhum Razi
05:00 PM - 06:00 PM CDT	Abstract	18-006 - Utilization and Dissemination of the VISIBL-MS Tool to Increase Awareness of Multiple Sclerosis in a Multi-state Rural Population in the United States Jaime Imitola, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	18-008 - Racial Disparities in Multiple Sclerosis: Differences in Neurodegeneration, Metabolism, Cognition, and Motor Functions in Black and White Patients Anas Z. Nourelden, MD
05:00 PM - 06:00 PM CDT	Abstract	18-009 - Bridging the Gap: Engaging Non-traditional Research Sites to Increase Participation in Multiple Sclerosis Clinical Research Andrew Wolf, MD
05:00 PM - 06:00 PM CDT	Abstract	18-010 - Comparative Effects of Disease-modifying Therapies on Cognition, Retinal and Clinical Outcomes in African American and Non-African American Patients with Multiple Sclerosis: A 24-month Prospective Study Brenda V. Ropero, MD
05:00 PM - 06:00 PM CDT	Abstract	10-001 - An Assessment of Acute Pharmacodynamic Drug-drug Interactions (PD-DDIs) Between Cannabidiol (CBD) and Cenobamate (CNB) in a Mouse Model of Generalized Tonic Seizures Karthik N. Rajasekaran, PhD
05:00 PM - 06:00 PM CDT	Abstract	10-002 - Pharmacokinetic Interaction Between Cenobamate and Lamotrigine: Real-world Evidence from a Single-center Cohort Venkata Sai Manikant Sanikommu
05:00 PM - 06:00 PM CDT	Abstract	10-003 - Efficacy and Safety of Adjunctive Cenobamate for the Treatment of Primary Generalized Tonic-clonic Seizures in Adults and Adolescents Pavel Klein, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	10-004 - Splicing-dependent Modulation of CaV1.3 Calcium Channels: Implications for Neurological Disease and Therapeutic Targeting Md Mostafizur Rahman, MBBS, MS
05:00 PM - 06:00 PM CDT	Abstract	10-005 - Combination Cannabidiol and Ketogenic Diet Therapy in Epilepsy Lauren Hinkley
05:00 PM - 06:00 PM CDT	Abstract	10-006 - Tocilizumab Effectiveness in Refractory Epilepsy in Patients with Autoimmune Encephalitis Associated Epilepsy Kelsey Williams
05:00 PM - 06:00 PM CDT	Abstract	10-007 - Beyond Clinical Trials: Cenobamate’s Effectiveness in Diverse Epilepsy Populations Shenney Lin, MS-2
05:00 PM - 06:00 PM CDT	Abstract	10-008 - Mortality Risk After Initiation of Cenobamate or Other Antiseizure Medications Philip Webber, PhD
05:00 PM - 06:00 PM CDT	Abstract	10-009 - Opakalim (BHV-7000) Potentiates the Activity of Kv7.2/7.3 Channels Containing a Single Copy of the Kv7.2 DEE-Causing Mutation, G281E Steven Dworetzky
05:00 PM - 06:00 PM CDT	Abstract	10-010 - In Vitro Enteral Feeding Tube Study for Lacosamide Extended-release Capsules Marie Tan, MD
05:00 PM - 06:00 PM CDT	Abstract	4-001 - A 24-Year Nationwide Analysis of Obstructive Sleep Apnea and Stroke-related Mortality Trends in the United States Allison Mitchell
05:00 PM - 06:00 PM CDT	Abstract	4-002 - Hemimasticatory Spasm Secondary to an Anterior Inferior Cerebellar Artery Loop Treated with Botulinum Injection Jason Becker, MD
05:00 PM - 06:00 PM CDT	Abstract	4-003 - Direct Oral Anticoagulants for Cerebral Venous Thrombosis: Equivalent Efficacy, Superior Safety Compared to Vitamin K Antagonists Mohammad Munim Zahoor, MD
05:00 PM - 06:00 PM CDT	Abstract	4-004 - Human Models in Mechanical Thrombectomy: A Comparative Review of Cadaveric, Perfused, and Ex Vivo Platforms Naser Hamad, Medical Student
05:00 PM - 06:00 PM CDT	Abstract	4-005 - Blood Pressure Management in Reperfused Ischemic Stroke: A Cochrane Systematic Review and Meta-analysis Lucia Belen Varela
05:00 PM - 06:00 PM CDT	Abstract	4-006 - Unilateral Anterior Spinal Cord Infarction After Vertebral Artery Aneurysm Flow Diversion: A Case Report Deya'a I. Alasmar, MD
05:00 PM - 06:00 PM CDT	Abstract	4-007 - Examining Specialty and Regional Trends in Anticoagulant Management of Cerebral Venous Thrombosis Shravani Khisti
05:00 PM - 06:00 PM CDT	Abstract	4-008 - Middle Meningeal Artery Embolization for Acute and Acute-on-chronic Subdural Hematomas: A Retrospective Cohort Study Daniel Isaza Pierotti, MD, MCSO
05:00 PM - 06:00 PM CDT	Abstract	4-009 - Cerebral Venous Infarct Mimicking High-Grade Glioma in a Liver Transplant Recipient Teresa Howard
05:00 PM - 06:00 PM CDT	Abstract	4-010 - A Wearable Sensor-based Platform for Promoting Post-stroke Motor Recovery Ram Kinker Mishra, PhD
05:00 PM - 06:00 PM CDT	Abstract	4-011 - Stroke in the Dominican Republic: Exploring Clinical and Treatment Trends in a Tertiary Hospital Marian A. Javier
05:00 PM - 06:00 PM CDT	Abstract	4-012 - Pattern of Brain Parenchymal Damage Related to Glymphatic System Dysfunction: Longitudinal Evidence from a Community-based Cohort Chengqian Li, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	4-013 - The Role of Diabetes on Stroke Recurrence in Cryptogenic Acute Ischemic Stroke Patients with Uterine Myomas Saisree Ravi, MD
05:00 PM - 06:00 PM CDT	Abstract	4-014 - Benefits of Close Monitoring of Intracranial Atherosclerotic Disease Patients in Comprehensive Stroke Clinic Yasmin Minai, BS
05:00 PM - 06:00 PM CDT	Abstract	4-015 - Comorbidities that Affect the Mortality Rate Between Ischemic and Hemorrhagic Stroke: A Retrospective Cohort Study Sharon Elumelu
05:00 PM - 06:00 PM CDT	Abstract	4-016 - A Triple Intersection: Pediatric Meningoencephalitis Complicated by Venous Sinus Thrombosis, CNS Vasculitis, and Multifocal Infarcts Nicholas Briski, MD
05:00 PM - 06:00 PM CDT	Abstract	4-017 - The Influence of Teaching vs. Non-teaching Hospitals on Length of Stay and Discharge Status for Adult CVT Patients Shreya Chalapalli
05:00 PM - 06:00 PM CDT	Abstract	4-018 - Cervical Spinal Arteriovenous Fistula Presenting as Acute Stroke: Diagnostic Pitfalls and Post-thrombolytic Complications Curtis A. Amankwah, MD
05:00 PM - 06:00 PM CDT	Abstract	4-019 - Association Between Mental Health Disorders and Anticoagulation Adherence in Patients with Non-valvular Atrial Fibrillation (NVAF) and the Impact on Ischemic Stroke Outcomes in Kaiser Permanente Southern California Patients Navdeep Sangha, MD
05:00 PM - 06:00 PM CDT	Abstract	4-020 - Small Vessel and Glymphatic Dysfunction In Asymptomatic Intracranial Atherosclerosis Relates to Cognition and Predicts Decline Yinxi Zou, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	4-021 - Assessing the AOU Database for Vascular Complications of Prescribed Stimulants Neema Darabi, BS
05:00 PM - 06:00 PM CDT	Abstract	4-022 - Assessing Hemorrhagic Risk after Revascularization in Acute Ischemic Stroke: The Role of the HAS-BLED Score Jose De Los Santos, MD
05:00 PM - 06:00 PM CDT	Abstract	19-001 - Risk Analysis Index Outperforms Modified Frailty Index-5 in Predicting Mortality and Discharge Disposition Following Adult Spinal Deformity Surgery: A National Database Analysis Abdullah Serhan, MD
05:00 PM - 06:00 PM CDT	Abstract	19-002 - Risk Analysis Index Outperforms Modified Frailty Index for Predicting Discharge Disposition after Anterior Lumbar Interbody Fusion in Black Patients: A Retrospective National Cohort Study Abdullah Serhan, MD
05:00 PM - 06:00 PM CDT	Abstract	19-003 - Guillain-Barré Syndrome (GBS) is Associated With Substantial Mortality Burden: A U.S. Claims-based Study of Individuals Hospitalized With GBS Jessica Hunt, PharmD
05:00 PM - 06:00 PM CDT	Abstract	19-004 - An Open-label Study Evaluating the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Tanruprubart Single Dose in Participants From North America and Europe With Guillain-Barré Syndrome Kavita M. Grover, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	19-005 - Acute and Chronic Life-altering Consequences of Guillain-Barré Syndrome: A Qualitative Study Identifies Significant Unmet Need for Timely Diagnosis and Appropriate Treatment Bismay Mishra
05:00 PM - 06:00 PM CDT	Abstract	19-006 - The Neuropathy Pressure Injury Paradox: Neurological Risk Quantification in Critical Care Shankar Biswas, MD
05:00 PM - 06:00 PM CDT	Abstract	19-007 - Safety and Efficacy of Thrombin Gelatin Matrix Sealants in Lumbar Spinal Surgery: A Systematic Review and Meta-analysis Basanta Pathak, MBBS
05:00 PM - 06:00 PM CDT	Abstract	19-008 - Neural Network-assisted Prediction of Venous Thromboembolism after Spine and Neurological Operations - NeuroVeT Study Suchita Mylavarapu, MBBS
05:00 PM - 06:00 PM CDT	Abstract	19-009 - A Rare Case of a Spinal Aneurysmal Bone Cyst Causing Thoracic Myelopathy Treated With a Unique Multimodal Approach Sunaina Rao, MD
05:00 PM - 06:00 PM CDT	Abstract	19-010 - Precision Neurosurgery: Involving the Integration of 3D Brain Mapping, BCI Guided Diagnosis and Neuroprosthetic Intervention in Surgery Sanjana Palakodeti
05:00 PM - 06:00 PM CDT	Abstract	13-001 - Pharmacokinetics, Pharmacodynamics, and Safety of IVL3003: A Novel Long-acting Injectable Acetylcholinesterase Inhibitor Compared with Oral Donepezil Soyoung Youm
05:00 PM - 06:00 PM CDT	Abstract	13-002 - Effects of Pharmacologic Interventions on Objective Sleep Architecture and Continuity in Alzheimer’s Disease: A Network Meta-analysis of Randomized Trials Tejaswin Mariappan, MBBS
05:00 PM - 06:00 PM CDT	Abstract	13-003 - Clinical Improvisatory Music for Alzheimer’s Disease Anxiety and Caregivers (CIMAC): Preliminary Behavioral and Network Modulation Findings from Ongoing Trials Catherine Vidano
05:00 PM - 06:00 PM CDT	Abstract	13-004 - Include Us: A Pilot Study to Enhance Alzheimer’s Disease Research Literacy Among Black/African American Older Adults GaResia Woods
05:00 PM - 06:00 PM CDT	Abstract	13-005 - Alzheimer’s Disease Improvements Following Neurosurgical Regimens: A Systematic Review Jenna Boykin, Medical Student
05:00 PM - 06:00 PM CDT	Abstract	13-006 - The Role of Anti-hypertensive Drug Length of Use on Progression to Cognitive Impairment within the Alzheimer's Disease Neuroimaging Initiative Study Dataset Sindhu V. Potlapalli
05:00 PM - 06:00 PM CDT	Abstract	13-007 - Efficacy and Safety of Intranasal Insulin Therapy in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials Tirath Patel
05:00 PM - 06:00 PM CDT	Abstract	13-008 - Drug-specific Effects of GLP-1 Receptor Agonists on Dementia Risk: A Network Meta-analysis Arkansh Sharma
05:00 PM - 06:00 PM CDT	Abstract	13-009 - Comparative Effects of Pharmacologic Interventions on Subjective and Functional Sleep-Wake Outcomes in Alzheimer’s Disease: A Network Meta-Analysis of Randomized Controlled Trials Tejaswin Mariappan, MBBS
05:00 PM - 06:00 PM CDT	Abstract	13-010 - GLP-1 Receptor Agonists in Alzheimer’s Disease: A Living Systematic Review Integrating Clinical Trials, Real-world Evidence, and Translational Feasibility Aditya Jain, MBBS
05:00 PM - 06:00 PM CDT	Abstract	13-011 - Feasibility, Safety, and Real-world Implementation of a Telehealth-delivered tDCS Program for Cognitive Preservation in Mild Cognitive Impairment and Early Alzheimer’s Disease Ahlanna J. Olson
05:00 PM - 06:00 PM CDT	Abstract	13-012 - Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment Peter Johannsen, MD
05:00 PM - 06:00 PM CDT	Abstract	13-014 - Masupirdine (A Pure 5-HT6 Receptor Antagonist): Clinical Development Program Targeting Agitation in Alzheimer’s Dementia – Phase-3 Study Updates Ramakrishna Nirogi, PhD
05:00 PM - 06:00 PM CDT	Abstract	5-001 - To Anticoagulate or Not? Stroke Prevention in Atrial Fibrillation Patients with a Single Additional Stroke Risk Factor Arthur V. Gribachov, MD
05:00 PM - 06:00 PM CDT	Abstract	5-002 - Patients with Right-sided Infective Endocarditis are at Risk for Neurological Complications even Without a Patent Foramen Ovale Ofelia Cespedes Moreno, MD
05:00 PM - 06:00 PM CDT	Abstract	5-003 - Anticoagulation Versus Antiplatelet Therapy for Carotid and Vertebral Artery Dissection: A Multicenter Real-world Comparative Analysis Sunny Ssu-Yu Chen, Medical Student
05:00 PM - 06:00 PM CDT	Abstract	5-004 - Spouse and Partner Educational Attainment as a Risk Factor for Stroke: A Cross-sectional Analysis of 2024 National Health Interview Survey Data Caterina Rivera
05:00 PM - 06:00 PM CDT	Abstract	5-006 - Identifying Barriers to Medications Adherence and Outpatient Follow-up After Transient Ischemic Attack: A Cross-sectional study Chetna Dengri, MD
05:00 PM - 06:00 PM CDT	Abstract	5-007 - Remote Digital Monitoring to Assess Daily Blood Pressure after Hospitalization for Stroke Karishma A. Popli, MD, MBE
05:00 PM - 06:00 PM CDT	Abstract	5-008 - Comparing Stenting with Medical Therapy Versus Medical Therapy Alone in Patients with Intracranial Atherosclerotic Stenosis: A Current Systematic Review and Meta-analysis Thamer S. Alhowaish, MD
05:00 PM - 06:00 PM CDT	Abstract	5-010 - Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis Sarika Mutyala, MBBS
05:00 PM - 06:00 PM CDT	Abstract	5-011 - Argatroban Plus Antiplatelet Therapy Versus Antiplatelet Alone in Acute Ischemic Stroke: A GRADE Assessment Systematic Review and Meta-analysis. Ahmed Negida, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	5-012 - Feasibility of Digital Health and Wearable Technology Interventions for Secondary Stroke Prevention Shervin Badihian, MD
05:00 PM - 06:00 PM CDT	Abstract	5-013 - Cardiac CTA Findings in Patients with Acute Ischemic Stroke and Indications for Secondary Stroke Prevention Marcus Milani
05:00 PM - 06:00 PM CDT	Abstract	5-014 - Comparative Efficacy and Safety of Direct Oral Anticoagulants vs Other Agents in Patients Diagnosed with Atrial Fibrillation Having Previous Stroke or Transient Ischemic Attack: Systematic Review and Meta-analysis Sakina Shaikh
05:00 PM - 06:00 PM CDT	Abstract	5-015 - Incidence and Risk Factors of Transient Global Amnesia at High Altitudes David J. Alexander, MS2
05:00 PM - 06:00 PM CDT	Abstract	5-016 - Triple and Quadruple Cervical Artery Dissection: Discussion and Literature Review Alexander Vorobyev, MD
05:00 PM - 06:00 PM CDT	Abstract	5-017 - Outcome of Ischemic Stroke Patients with Low Ejection Fraction on SGLT-2 Inhibitor Staci P. Hunter, DO
05:00 PM - 06:00 PM CDT	Abstract	5-018 - Comparative Outcomes of Embolization Techniques for Chronic Subdural Hematoma Mohammad Abubakr, BS
05:00 PM - 06:00 PM CDT	Abstract	5-019 - Common Carotid Artery Pseudoaneurysm After Stent Placement for Symptomatic Carotid Web: Case Report and Updated Systematic Review of the Literature Nikhil Vj, Student
05:00 PM - 06:00 PM CDT	Abstract	5-020 - Predictors and Outcomes of 30-Day Readmissions in Patients Hospitalized for Acute Ischemic Stroke Undergoing Mechanical Thrombectomy Khadija Tanvir, MBBS
05:00 PM - 06:00 PM CDT	Abstract	5-022 - Prognostic Models in Posterior Circulation Stroke: Current Evidence and Future Directions Hyunah Choi, MD
05:00 PM - 06:00 PM CDT	Abstract	5-023 - Social Vulnerability Does Not Predict 3-Month Functional Outcomes After Mechanical Thrombectomy Nikolas A. Melkumyan
05:00 PM - 06:00 PM CDT	Abstract	16-001 - Younger Groundwater Associated with Greater Risk of Parkinson’s Disease in Nationwide Medicare Study: Implications of Aquifer Type Brittany Krzyzanowski, PhD
05:00 PM - 06:00 PM CDT	Abstract	16-002 - Mortality Burden of Parkinson’s Disease versus Parkinson’s Disease with Aspiration Pneumonia Among Older Adults: A Retrospective Analysis from CDC-WONDER (1999-2023) Muhammad Saim, MBBS
05:00 PM - 06:00 PM CDT	Abstract	16-003 - Neuropsychiatric Features of Parkinson's Disease And Parkinsonism: A Population-based Study 1991-2020 Emanuela Santoro, Medical student
05:00 PM - 06:00 PM CDT	Abstract	16-004 - Gender-based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study Zhimin Xu, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	16-005 - Paraquat Exposure and Parkinson’s Disease Risk in the United States: A Meta-analysis of Epidemiologic Studies Jamir Pitton Rissardo, MD
05:00 PM - 06:00 PM CDT	Abstract	16-006 - Manganese-induced Parkinsonism: A Review of Etiologies and Treatments Nitish Khindri
05:00 PM - 06:00 PM CDT	Abstract	16-007 - Burden of Parkinson’s Disease in South Asia, 1990–2023: Findings from the Global Burden of Disease Study 2023 Bhumi D. Patel
05:00 PM - 06:00 PM CDT	Abstract	16-008 - Overlap of Parkinson's Disease and Respiratory Failure in Older Adults: Epidemiologic Insights from CDC-WONDER Database (1999-2020) Muaz Ali, MD
05:00 PM - 06:00 PM CDT	Abstract	16-009 - Mortality Trends in Parkinson’s Disease: Analysis of Top Comorbid Causes of Death Using CDC WONDER, 1999-2020 Samer hamed Mohamed Hamed Amer Salama, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	16-010 - National Mortality Trends and Forecasts of Parkinson’s Disease With Psychiatric Comorbidities Among Older Adults in the United States,1999–2023 Minahil Zaheer, MBBS
05:00 PM - 06:00 PM CDT	Abstract	16-011 - Prevalence of Pathogenic CSF1R Variants in a Large Genomic Cohort: Insights from the Mayo Tapestry Study Lukasz Milanowski, MD
05:00 PM - 06:00 PM CDT	Abstract	16-012 - Clinical Associations of Weight Loss in Early Parkinson's Disease Claire Wu, Student
05:00 PM - 06:00 PM CDT	Abstract	16-013 - Unmasking the Risk: Aspiration Pneumonia in Parkinson’s Disease Marina Santos De Sousa, MD
05:00 PM - 06:00 PM CDT	Abstract	16-014 - Disparities in Mortality Related to Coexisting Parkinson’s Disease and Chronic Obstructive Pulmonary Disease in the United States: A CDC-WONDER Analysis (1999–2020) Muaz Ali, MD
05:00 PM - 06:00 PM CDT	Abstract	16-015 - Predictive Risk Factors of Cognitive Impairment and Dementia in a Population-based Cohort of Incident Parkinsonism in Olmsted County Lorenzo Malfer, MD
05:00 PM - 06:00 PM CDT	Abstract	2-001 - Clinical Profile Radiologic Features and Outcomes in Children with Acute Necrotizing Encephalopathy: A Comparative Study of Tocilizumab Use Lokesh Saini, DM
05:00 PM - 06:00 PM CDT	Abstract	2-002 - Every Minute Blinds: Temporal Artery Ultrasound in the Real-time Diagnosis of Stroke of the Eye Suhas Gangadhara, MD
05:00 PM - 06:00 PM CDT	Abstract	2-003 - Neurocognitive Complications of Lupus: A Multidisciplinary Program for Advanced Diagnostics, Management, and Clinical Research Douglas R. Wilcox, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	2-004 - The Diagnostic Value of Minor Salivary Gland Biopsy in the Evaluation of Neuroimmunological Diseases Asli Tuncer
05:00 PM - 06:00 PM CDT	Abstract	2-005 - Neuropsychological Sequelae of Pediatric Autoimmune Encephalitis: a Descriptive Case Series Yoji Hoshina, MD
05:00 PM - 06:00 PM CDT	Abstract	2-006 - Optical Coherence Tomography (OCT) as a Diagnostic Tool in Sarcoidosis-associated Optic Neuropathy Ruth Andrea Salazar Camelo, MD
05:00 PM - 06:00 PM CDT	Abstract	2-007 - Role of Bruton Tyrosine Kinase (BTK) in CNS Host Defense Farinaz Safavi, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	2-008 - Efgartigimod is a Unique FcRn Blocker That Allows IgG Reduction Without Broad Inhibition of Immune Responses Kristin Heerlein
05:00 PM - 06:00 PM CDT	Abstract	2-009 - Comparative Sensitivity of FDG-PET/CT and Contrasted CT in Identifying Biopsy Targets in Neurosarcoidosis Adam Morehead, MD
05:00 PM - 06:00 PM CDT	Abstract	2-010 - Clinical Characterization of Neuro-Behcet’s Disease in a North American Cohort Avanteeka Ganguly
05:00 PM - 06:00 PM CDT	Abstract	2-011 - First-line Induction Therapy for Hospitalized Patients with Primary CNS Vasculitis Edith Graham, MD
05:00 PM - 06:00 PM CDT	Abstract	2-012 - Post-vaccine Myelitis: A Rare Event Often Overemphasized Daniela Riveros Acosta, MD
05:00 PM - 06:00 PM CDT	Abstract	2-013 - Cerebral Amyloid Angiopathy-related Inflammation: A Spectrum of Presentation and Response to Therapy in Three Patients Nirbha Ghurye, MBBS
05:00 PM - 06:00 PM CDT	Abstract	2-014 - A Report of Epilepsy and Encephalopathy Due to RA-Associated Pachymeningitis Alexander P. Gabrielli, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-001 - Switching to CREXONT® Improves “Good On” Time and Reduces Motor Fluctuations in Parkinson’s Disease: Interim Results from the Real-world ELEVATE-PD Phase Four Study Robert A. Hauser, MD, MBA, FAAN
05:00 PM - 06:00 PM CDT	Abstract	17-002 - Comparative Efficacy of Opicapone and Entacapone in the Management of Motor Fluctuations in Parkinson’s Disease Ghazal Banisadr, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-003 - CREXONT® (IPX203, ER CD-LD) Super-responders: Enhanced Symptom Control in Parkinson’s Disease Simon Allard, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-004 - Simplified Twice-daily CREXONT® Regimen Delivers Significant Gain in “Good On” Time in Parkinson’s Patients with Lower Levodopa Needs Simon Allard, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-005 - Effectiveness of Foslevodopa/Foscarbidopa in Subgroups of Patients Earlier within Advanced Parkinson’s Disease in an Interim Dataset of ROSSINI Lars Bergmann, MD
05:00 PM - 06:00 PM CDT	Abstract	17-006 - Foslevodopa/Foscarbidopa Improves Pain in People with Advanced Parkinson’s Disease Who Have Uncontrolled Motor Fluctuations: Interim Results From the Real-world ROSSINI Study Lars Bergmann, MD
05:00 PM - 06:00 PM CDT	Abstract	17-007 - Efficacy and Predictors of Discontinuation of Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion Therapy in a Parkinson’s Disease Cohort Lorenzo Malfer, MD
05:00 PM - 06:00 PM CDT	Abstract	17-008 - Symptomatic Neurogenic Orthostatic Hypotension: Improvement with Continuous Foscarbidopa/Foslevodopa Infusion Somil Bhushan
05:00 PM - 06:00 PM CDT	Abstract	17-009 - Successful Treatment of Refractory Gastroparesis-related Nausea in Parkinson’s Disease with Mirtazapine Emma J. Orozco, MD
05:00 PM - 06:00 PM CDT	Abstract	17-010 - Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose Helena Brigas, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-011 - Foslevodopa/Foscarbidopa Reduces Troublesome Dyskinesia in People with Advanced Parkinson’s Disease in Two Phase Three Clinical Trials Robert A. Hauser, MD, MBA, FAAN
05:00 PM - 06:00 PM CDT	Abstract	17-012 - Effect of Opicapone on Sleep-related Complaints and Non-motor Burden in Parkinson’s Patients: A Post-hoc Analysis of the OASIS Trial Ghazal Banisadr, PhD
05:00 PM - 06:00 PM CDT	Abstract	17-013 - Pimavanserin for Parkinson’s Disease Psychosis: A Meta-analysis of Placebo-controlled Randomized Trials Matthew Petruncio
05:00 PM - 06:00 PM CDT	Abstract	17-014 - Memantine for Parkinson’s Disease: Does It Make a Difference? Aswathi Sajeendran, MD
05:00 PM - 06:00 PM CDT	Abstract	17-015 - Effect of CREXONT® (IPX203, ER CD-LD) on Sleep in Patients with Parkinson’s Disease and Associated Sleep Disturbances Stanley Fisher, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	17-016 - Efficacy and Safety of CVT-301 in Parkinson’s Disease: A Network Meta-analysis Muaz Ali, MD
05:00 PM - 06:00 PM CDT	Abstract	17-017 - Non-pharmacologic Interventions for Hispanic and Latino Caregivers of Persons with Parkinson’s Disease Charlotte Slavick
05:00 PM - 06:00 PM CDT	Abstract	11-001 - Clinical Stages of Lafora Progressive Myoclonus Epilepsy Viet-Huong Nguyen, PharmD, MPH, MS
05:00 PM - 06:00 PM CDT	Abstract	11-002 - Validation of Pediatric Idiopathic Generalized Epilepsy Diagnoses from the Danish National Patient Register During 1994-2019 Magnus Spangsberg Boesen, MD
05:00 PM - 06:00 PM CDT	Abstract	11-003 - Distinct Medial Temporal Volumetric Signatures in Extra-medial Temporal Lobe Lesional Epilepsy Yonatan Serlin, MD
05:00 PM - 06:00 PM CDT	Abstract	11-004 - Wada Test Using Etomidate: Single Center Experience Muhammad Khalid, MD
05:00 PM - 06:00 PM CDT	Abstract	11-005 - Glucose Metabolism of the Cerebellum in Temporal Lobe Epilepsy with Hippocampal Sclerosis YU-CHI CHAO, MD
05:00 PM - 06:00 PM CDT	Abstract	11-006 - Complementary and Alternative Medicine Use Among Adults with Epilepsy or Seizures Angela Liu
05:00 PM - 06:00 PM CDT	Abstract	11-007 - Treatment Experiences with Anti-seizure Medications (ASMs): Patient and Clinician Perspectives on Titration Burden, Quality of Life, and No-Titration Options Andrew Zillgitt, DO
05:00 PM - 06:00 PM CDT	Abstract	11-008 - Develop and Assess the Efficacy of a Neuro-cognitive and Psychosocial Intervention Module in Patients with Drug-resistant Epilepsy: A Randomized Controlled Trial Neetu Choudhary IV, PhD
05:00 PM - 06:00 PM CDT	Abstract	11-009 - Quality Improvement Project: Initial Evaluation and Management of Breakthrough Seizures Amaya De La Pena, MD
05:00 PM - 06:00 PM CDT	Abstract	11-010 - WADA Test in Non-English-speaking Patients with Refractory Epilepsy Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN
05:00 PM - 06:00 PM CDT	Abstract	11-011 - Impact of Early Immunotherapy on Seizure Control and Recovery in Autoimmune-associated Encephalitis Kassem Al Asaad, MBBS
05:00 PM - 06:00 PM CDT	Abstract	20-001 - Progression Independent of Relapse Activity in Relapsing Multiple Sclerosis Afif Hentati, MD
05:00 PM - 06:00 PM CDT	Abstract	20-002 - Real-world Use of Cladribine in Adults With Multiple Sclerosis Kyle Smoot, MD, FAAN
05:00 PM - 06:00 PM CDT	Abstract	20-003 - Which Medication Improves Fatigue in Patients With Multiple Sclerosis (MS)?: A Systematic Review and Network Meta-analysis Mahsa Ghajarzadeh, MD
05:00 PM - 06:00 PM CDT	Abstract	20-004 - Impact of MRI Activity and Medical Comorbidities on Serum Neurofilament Light Chain in Multiple Sclerosis Hira Chouhdry, MD
05:00 PM - 06:00 PM CDT	Abstract	20-005 - Association Between Gastrointestinal Symptoms and Disease Severity in Multiple Sclerosis Patients Vaisnavy Govindasamy, MBBS
05:00 PM - 06:00 PM CDT	Abstract	20-006 - Subcortical Brain Volume is Associated With Patient-related Measures of Working Memory Maintenance in Multiple Sclerosis Laya Rajan, PhD
05:00 PM - 06:00 PM CDT	Abstract	20-007 - Home-based Transcranial Direct Current Stimulation (tDCS) Paired With Mindfulness for Cannabis Withdrawal in Women With Multiple Sclerosis: Predictors and Affective Correlates of Response Shayna Pehel
05:00 PM - 06:00 PM CDT	Abstract	20-008 - The Gut Microbiome in Pediatric-onset Acquired Demyelinating Syndromes by Myelin Oligodendrocyte Glycoprotein Antibody Status Wendy Tsai, MD
05:00 PM - 06:00 PM CDT	Abstract	20-009 - Sociodemographic and Clinical Factors in NMOSD and MOGAD: Disability, Psychiatric Burden, and Disparities Neha Patil
05:00 PM - 06:00 PM CDT	Abstract	20-010 - Tumefactive Demyelination in NMOSD Presenting as a Thalamic Lesion With Midline Shift Henry A. Herrera, MD
05:00 PM - 06:00 PM CDT	Abstract	20-011 - Neuroanatomical Volume Patterns Across Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), and Myelin Oligodendrocyte Glycoprotein Antibody– Associated Disease (MOGAD): A Systematic Review and Network Meta-analysis Hassan K. Salamatullah, Sr.
05:00 PM - 06:00 PM CDT	Abstract	20-012 - Clinical Characteristics of Subacute vs. Acute Presentations of Neuromyelitis Optica Spectrum Disorder Humza Qureshi
05:00 PM - 06:00 PM CDT	Abstract	14-001 - Feasibility of Five Times Sit-to-Stand Assessment (5xSTS) in Stroke Using a Smartphone Vicky Chan, PT
05:00 PM - 06:00 PM CDT	Abstract	14-002 - Resting-state Motor Network Connectivity may Reflect Upper Limb Function in Chronic Stroke Neha Sudarshan
05:00 PM - 06:00 PM CDT	Abstract	14-003 - Changes in Self-Reported Cognitive Complaints, Functional Impairments, Work Productivity, and Symptom Severity in Participants With Narcolepsy After Treatment With Greater Than 9 Gram Dosages of Low-Sodium Oxybate in the DUET Study Logan D. Schneider, MD
05:00 PM - 06:00 PM CDT	Abstract	14-004 - Hypoxia Affects Glymphatic Efficiency: Assessing Glymphatic Disruption in Obstructive Sleep Apnea Using Near-infrared Spectroscopy Sujasha Gupta, PhD
05:00 PM - 06:00 PM CDT	Abstract	14-005 - Neural Signatures of Conscious Experience During Sleep: A Serial Awakening Study Using High-density EEG Atakan Selte, MD
05:00 PM - 06:00 PM CDT	Abstract	14-006 - Intracranial Pressure and Obstructive Sleep Apnea: A Systematic Review of Mechanisms, Clinical Links, and Treatment Effects Tabish W. Siddiqui
05:00 PM - 06:00 PM CDT	Abstract	14-007 - Improvement of Sleep-related Eating Disorder With a GLP-1 Receptor Agonist Subhendu Rath, MBBS
05:00 PM - 06:00 PM CDT	Abstract	14-008 - Effect of Vitamin D3 Supplementation on Sleep Quality in Deficient Adults : A Randomized Controlled Trial Lakshmi Priya Lalitha, MD
05:00 PM - 06:00 PM CDT	Abstract	14-009 - Sleep Management in a Patient With YWHAG-related Developmental Epileptic Encephalopathy Alizah A. Patterson, MD
05:00 PM - 06:00 PM CDT	Abstract	14-010 - Quantitative Differences in REM Sleep Without Atonia Among Narcolepsy Type One, Narcolepsy Type Two, and Idiopathic Hypersomnia Sikawat Thanaviratananich, MD
05:00 PM - 06:00 PM CDT	Abstract	14-011 - Longitudinal Trajectory of Post-COVID Sleep Disturbance and its Relationship With Other Long-COVID Symptoms Kijeong Kim, MD
05:00 PM - 06:00 PM CDT	Abstract	14-012 - Elevated Influenza Antibodies in Recent Onset Type-one Narcolepsy Bruna de Freitas Dias, MD
05:00 PM - 06:00 PM CDT	Abstract	8-001 - Evaluating the Therapeutic Potential of Geranylgeraniol (GGOH) in an iPSC-Derived Duchenne Muscular Dystrophy Disease Model Johnnie Turner
05:00 PM - 06:00 PM CDT	Abstract	8-003 - Lived Experiences and Challenges Among Caregivers of Children with Dystrophinopathies in Zambia: A Qualitative Study. Namita Patel, MD
05:00 PM - 06:00 PM CDT	Abstract	8-004 - Social Drivers of Brain Health: The Duchenne Muscular Dystrophy Experience Varsha Penumalee
05:00 PM - 06:00 PM CDT	Abstract	8-005 - Preliminary Prospective Study of Pharmaceutical-grade Cannabidiol for Seizure Frequency and Comorbid Anxiety Symptoms in Pediatric Epilepsy: Associations with Circulating Endocannabinoids and Related Lipid Biomarkers Sophia Hopkins
05:00 PM - 06:00 PM CDT	Abstract	8-006 - Seizures in Term & Preterm Neonates: A U.S. Population-based Analysis for Resource Utilization and Mortality Trends (2016-2022) Snigdha Kosuri, MPH
05:00 PM - 06:00 PM CDT	Abstract	8-007 - Healthcare Utilization, Physical, and Mental Health, and Food Security Among Pediatric Patients with Epilepsy Sara Lee, MD
05:00 PM - 06:00 PM CDT	Abstract	8-008 - From Regression to Revelation: SHANK3-related Phelan-McDermid Syndrome Presenting as Lennox-Gastaut Syndrome Jose F. Ortega Tola, MD
05:00 PM - 06:00 PM CDT	Abstract	8-009 - Automated Behavioral Quantification of Scn1b Null Mice Using LabGym: A Platform for High-throughput Phenotyping of Epilepsy Joshua M. Adams, MD, PhD
05:00 PM - 06:00 PM CDT	Abstract	8-010 - Clinical Presentation of a Cohort of Pediatric Epilepsy Patients with Ventriculoperitoneal Shunt Madison Estrela
05:00 PM - 06:00 PM CDT	Abstract	8-011 - RHOBTB2: A Unique Developmental Epileptic Encephalopathy Sapna Shah, MD

Faculty Disclosures
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
William H. Theodore, MD, FAAN	Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities.
Emmanuel Mignot, MD, PhD	Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Barbara G. Vickrey, MD, MPH, FAAN	The institution of Dr. Vickrey has received research support from NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a Grant reviewer, committee co-chair with NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a conference advisory committee with University of Rochester. Dr. Vickrey has a non-compensated relationship as a Second Vice President with Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee member of Stroke Council with American Heart Association that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee Chair with American Neurological Association that is relevant to AAN interests or activities.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Shafeeq Ladha, MD	Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Kyle Smoot, MD, FAAN	Dr. Smoot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Smoot has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Smoot has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Smoot has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMDSerono. Dr. Smoot has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Smoot has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Smoot has received research support from Genzyme. The institution of Dr. Smoot has received research support from EMDSerono. The institution of Dr. Smoot has received research support from Genentech.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
M. M. Mesulam, MD, FAAN	Dr. Mesulam has received publishing royalties from a publication relating to health care.
Brad A. Racette, MD, FAAN	Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Emily Klatte, MD	Dr. Klatte has received personal compensation in the range of $0-$499 for serving as a Consultant for SK Life Science . Dr. Klatte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis, Inc. Dr. Klatte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis.
Joohi Jimenez Shahed, MD, FAAN	Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Maria Behrens, MD, PhD	No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Jason Lerner, MD	Dr. Lerner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Lerner has or had stock in Biohaven Pharmaceuticals.
Joseph E. Safdieh, MD, FAAN	Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Eric H. Kossoff, MD	Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Kossoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simply Good Foods. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cambrooke. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Takashi Yamamura, MD	Dr. Yamamura has nothing to disclose.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Stanley Fisher, MD, FAAN	Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Teena Shetty, MD, FAAN	Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Daniel Becker, MD	Dr. Becker has nothing to disclose.
Jeffrey A. Allen, MD	Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Peter A. LeWitt, MD	Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Victor Valcour, MD	Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IAS-USA. Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Susan Criswell, MD	Dr. Criswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.
Ramon L. Rodriguez Cruz, MD, FAAN	The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Mohamad Koubeissi, MD, FAAN	Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Cris S. Constantinescu, MD, PhD	Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Fen Bao	Fen Bao has nothing to disclose.
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Kazuo Fujihara, MD	Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Antonio V. Delgado-Escueta, MD	Dr. Delgado-Escueta has nothing to disclose.
John Papatriantafyllou, MD	Dr. Papatriantafyllou has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Sharon Hassin-Baer, MD	Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Olivier Rascol, MD, PhD	Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Benjamin J. Osborne, MD, FAAN	Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Timea M. Hodics, MD	An immediate family member of Dr. Hodics has received personal compensation for serving as an employee of CRG. An immediate family member of Dr. Hodics has stock in Approximately 40 public and private companies . An immediate family member of Dr. Hodics has received intellectual property interests from a discovery or technology relating to health care.
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
David J. Walsh, MD	No disclosure on file
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Heather Adams	The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
Steven M. Wolf, MD	Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurilis. Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MOnteris . Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus . The institution of Dr. Wolf has received research support from Neuropace. The institution of Dr. Wolf has received research support from Eisai. The institution of Dr. Wolf has received research support from Aguestive. The institution of Dr. Wolf has received research support from Neurilis . The institution of Dr. Wolf has received research support from UCB. The institution of Dr. Wolf has received research support from SKLife . The institution of Dr. Wolf has received research support from Longboard . The institution of Dr. Wolf has received research support from Takeda. The institution of Dr. Wolf has received research support from biohaven. The institution of Dr. Wolf has received research support from Assertio. Dr. Wolf has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care.
William J. Litchy, MD, FAAN	Dr. Litchy has nothing to disclose.
David G. Vossler, MD, FAAN	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care.
Mill Etienne, MD, MPH, FAAN	Dr. Etienne has nothing to disclose.
Donald A. Barone, DO	Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vanda. Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Jason L. Aldred, MD, FAAN	Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $0-$499 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from NeuroDerm. The institution of Dr. Aldred has received research support from PhotoPharma. The institution of Dr. Aldred has received research support from Lilly. Dr. Aldred has received research support from Capsida Biotherapeutics. Dr. Aldred has received research support from Teva. Dr. Aldred has received research support from Lundbeck. Dr. Aldred has received research support from Denali Therapeutics. Dr. Aldred has received research support from Intra-Cellular Therapies Inc.. Dr. Aldred has received research support from Vima Therapeutics. Dr. Aldred has received research support from Ventus Therapeutics. Dr. Aldred has received research support from Scion NeuroStim .
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Clifton L. Gooch, MD, FAAN	Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Joseph V. Campellone, MD, FAAN	Dr. Campellone has received personal compensation in the range of $5,000-$9,999 for serving as a Content reviewer with VeriMed.
Steven K. Feske, MD	Dr. Feske has received publishing royalties from a publication relating to health care.
David G. Standaert, MD, PhD, FAAN	Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Andrew Singleton	An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
Young-Min Lim, MD	Dr. Lim has nothing to disclose.
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Helen Tremlett, PhD, BPharm	Dr. Tremlett has nothing to disclose.
Mackenzie Cervenka, MD	Dr. Cervenka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nutricia. Dr. Cervenka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle Health Science/Vitaflo. The institution of Dr. Cervenka has received research support from Nestle Health Science/Vitaflo. Dr. Cervenka has received publishing royalties from a publication relating to health care.
Dawn Eliashiv, MD, FAAN	Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for eisai. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Eliashiv has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic's. Dr. Eliashiv has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. The institution of Dr. Eliashiv has received research support from NINDS. The institution of Dr. Eliashiv has received research support from Neuropace. Dr. Eliashiv has received publishing royalties from a publication relating to health care.
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Peter B. Kang, MD, FAAN	Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurogene. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics (Italfarmaco). An immediate family member of Dr. Kang has received personal compensation in the range of $0-$499 for serving as a Consultant for Life Sciences Consultants. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MLAB Biosciences. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Kang has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Centers for Disease Control and Prevention (CDC). The institution of Dr. Kang has received research support from National Institutes of Health (NIH). The institution of Dr. Kang has received research support from Food and Drug Administration. The institution of Dr. Kang has received research support from National Initiative for Cockayne Syndrome. The institution of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Duchenne UK - PPMD. The institution of an immediate family member of Dr. Kang has received research support from Regenerative Medicine MN. The institution of an immediate family member of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of an immediate family member of Dr. Kang has received research support from NIH. The institution of an immediate family member of Dr. Kang has received research support from Viljem Julijan Association for Children with Rare Disease. The institution of Dr. Kang has received research support from Minnesota Partnership. Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. Dr. Kang has received publishing royalties from a publication relating to health care. Dr. Kang has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a President (Including President-Elect and Past President) with Child Neurology Society that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities.
Rebecca L. Sugg, MD, FAAN	Dr. Sugg has nothing to disclose.
Mona Bahouth, MD, PhD, FAAN	Dr. Bahouth has nothing to disclose.
Arthur Partikian, MD	Dr. Partikian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha Gene Therapies. Dr. Partikian has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sedgwick insurance. Dr. Partikian has stock in Taysha gene therapies. Dr. Partikian has stock in Roche. Dr. Partikian has stock in Stoke pharmaceutical . Dr. Partikian has received personal compensation in the range of $10,000-$49,999 for serving as a Neurology consultant with San Gabriel/Pomona Regional Center.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Marcelo Matiello, MD, FAAN	Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Jennie W. Taylor, MD	Dr. Taylor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. The institution of Dr. Taylor has received research support from BMS. The institution of Dr. Taylor has received research support from Servier. The institution of Dr. Taylor has received research support from Navio. Dr. Taylor has received research support from University of Colorado. Dr. Taylor has received research support from Mt Sinai University . Dr. Taylor has received publishing royalties from a publication relating to health care.
Ana C. Felix, MD, FAAN	Dr. Felix has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Zachary N. London, MD, FAAN	Dr. London has nothing to disclose.
Daniel Bandari, MD	The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Genila Bibat, MD	Dr. Bibat has nothing to disclose.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Petra Schwingenschuh, MD	Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
I-Hweii A. Chen, MD, PhD, FAAN	The institution of Dr. Chen has received research support from Healey Center at Massachusetts General Hospital. The institution of Dr. Chen has received research support from General Hospital Corporation. The institution of Dr. Chen has received research support from Argenx.
Andrew Bauerschmidt, MD	Dr. Bauerschmidt has nothing to disclose.
Laxman Bahroo, DO, FAAN	Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz.
Rebecca L. Gillani, MD	The institution of Dr. Gillani has received research support from The Phyllis and Jerome Lyle Rappaport Foundation. The institution of Dr. Gillani has received research support from McCourt Foundation . The institution of Dr. Gillani has received research support from Roche.
Michael P. Macken, MD, MRCPI	Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Macken has received research support from LivaNova.
W. O. Tobin, PhD, MBBCh, BAO, FAAN	Dr. Tobin has received publishing royalties from a publication relating to health care.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Ho Jin Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Afif Hentati, MD	Dr. Hentati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hentati has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Hentati has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for INSPE.
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Lisa D. Ravdin, PhD, ABPP-CN	Dr. Ravdin has nothing to disclose.
Andrew Knight	Andrew Knight has nothing to disclose.
Patrick J. Bosque, MD	Dr. Bosque has stock in Merck . The institution of Dr. Bosque has received research support from Sanofi.
Marjorie Bunch, MD	Dr. Bunch has a non-compensated relationship as a Professional Advisory Committee with Epilepsy Foundation that is relevant to AAN interests or activities.
David King-Stephens, MD	Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Eun-Jae Lee, MD, PhD	The institution of Prof. Lee has received research support from Republic of Korea .
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Pablo Mir, MD	Dr. Mir has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie, Abbott, Allergan, Bial, Merz, UCB, and Zambon. The institution of Dr. Mir has received research support from Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación) and by Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526, CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, and the Fundación Mutua Madrileña..
Glenn Morrison, PhD	Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
Erik L. Ortega, MD	Dr. Ortega has nothing to disclose.
Sokratis Papageorgiou, MD	Dr. Papageorgiou has nothing to disclose.
George M. Plotkin, MD, PhD	The institution of Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Pamela Rist, PhD	The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Matthew S. Robbins, MD, FAAN	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, American Academy of Neurology that is relevant to AAN interests or activities.
Megha Shah	Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Aimee Szewka, MD, FAAN	Dr. Szewka has nothing to disclose.
Mathula Thangarajh, MD, PhD, FAAN	Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NS Pharma.
Okeanis Vaou, MD, FAAN	Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Sandra Weintraub, PhD, FAAN	Dr. Weintraub has nothing to disclose.
Edward Yu, MD, FAAN	Dr. Yu has nothing to disclose.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Sandeep Thakkar, DO	Dr. Thakkar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for abbvie. Dr. Thakkar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Thakkar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine. Dr. Thakkar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Thakkar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for medtronic.
Roumen D. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Chiayi Chen, PhD, RN	Dr. Chen has nothing to disclose.
Yong Won Cho, MD	No disclosure on file
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Andrew H. Evans, MB, BS	Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. The institution of Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluerock. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encapsulate.
Robert Fekete, MD	Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Neuroscience, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink, Inc.. The institution of Dr. Fekete has received research support from Lundbeck. Dr. Fekete has received publishing royalties from a publication relating to health care. Dr. Fekete has a non-compensated relationship as a Neurological Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Juan C. Parra Riaza	Juan C. Parra Riaza has received personal compensation for serving as an employee of AbbVie INC. Juan C. Parra Riaza has stock in AbbVie INC.
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Tamela Stuchiner	Ms. Stuchiner has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Alexandra E. Hovaguimian, MD	Dr. Hovaguimian has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Julia O'Mahony	Ms. O'Mahony has nothing to disclose.
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Jose M. Serratosa, MD, PhD	No disclosure on file
David Chiu, MD	Dr. Chiu has nothing to disclose.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Evren Burakgazi, MD	Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK life Sciences. Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Vikram Bhise, MD	Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield.
Tianxia Wu	Tianxia Wu has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Daniel Jose Correa, MD, MSc, FAAN	Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has or had stock in Aidin Inc.Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.
David Bearden, MD	Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Amaal J. Starling, MD, FAAN	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Sumit Verma, MD	Dr. Verma has nothing to disclose.
Jennifer T. Kalina, MS	No disclosure on file
Sikawat Thanaviratananich, MD	Dr. Thanaviratananich has nothing to disclose.
Shelly D. Ozark, MD	Dr. Ozark has nothing to disclose.
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Michelle P. Kvalsund, DO	Dr. Kvalsund has nothing to disclose.
Christopher M. Zallek, MD	The institution of Dr. Zallek has received research support from OSF HealthCare (employer supported intramural research). Dr. Zallek has received intellectual property interests from a discovery or technology relating to health care.
Larisa Syrow, MD	Dr. Syrow has nothing to disclose.
Borna Bonakdarpour, MD, FAAN	Dr. Bonakdarpour has nothing to disclose.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Elias S. Sotirchos, MD	Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Claude Steriade, MD	The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals. Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Speakers Bureau with SK Life Sciences. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Speakers Bureau with Neurelis. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Xenon Pharmaceuticals.
Michael E. Bozik, MD	Dr. Bozik has received personal compensation for serving as an employee of Biohaven . Dr. Bozik has stock in Biohaven.
Sara Inati, MD	Dr. Inati has nothing to disclose.
Anna Marisa Cervantes-Arslanian, MD, FAAN	Dr. Cervantes-Arslanian has nothing to disclose.
Sudhir V. Datar, MD	Dr. Datar has nothing to disclose.
José H. Posas, MD, FAAN	Dr. Posas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Posas has or had stock in Dane Health.Dr. Posas has or had stock in Brainscope.Dr. Posas has a non-compensated relationship as a Advisor with Dane Health that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Lecturer with Concussion Corner Academy that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Advisor with Brainscope that is relevant to AAN interests or activities.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Karan S. Dixit, MD	Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Chrystal M. Reed, MD, PhD	Dr. Reed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint.
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Victor Ferastraoaru, MD	Dr. Ferastraoaru has nothing to disclose.
Sean Gratton, MD	Dr. Gratton has received personal compensation in the range of $0-$499 for serving as a Annual Meeting Planning Committee with Kansas City Clinical Neuroscience Society.
Harini Sarva, MD, FAAN	Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Chirag Gandhi	Chirag Gandhi has nothing to disclose.
Jennifer S. Yokoyama, PhD	The institution of Dr. Yokoyama has received research support from NIH. The institution of Dr. Yokoyama has received research support from Alzheimer's Association . The institution of Dr. Yokoyama has received research support from Mary Oakley Foundation. The institution of Dr. Yokoyama has received research support from Alector. The institution of Dr. Yokoyama has received research support from Transposon. The institution of Dr. Yokoyama has received research support from Rainwater Charitable Foundation.
Leonel Takada	No disclosure on file
Tiago Mestre, MD, MSC	Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHDI. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mestre has received research support from CIHR. The institution of Dr. Mestre has received research support from Ontario Research Fund. The institution of Dr. Mestre has received research support from MJFF. The institution of Dr. Mestre has received research support from Parkinson Canada. The institution of Dr. Mestre has received research support from University of Ottawa/PRC.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VOR. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. The institution of Dr. Vu has received research support from NMD Pharma. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with AcademicCME. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with CMEO. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with PER. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with MedLive.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Fahd Amjad, MD	Dr. Amjad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Amjad has received personal compensation in the range of $0-$499 for serving as a Consultant for abbvie. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowna Kirin. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for This information is included in the consultant disclosure. The institution of Dr. Amjad has received research support from Roche.
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Wolfgang Jost	Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Andrea Slachevsky, MD	No disclosure on file
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Nancy Gadallah, DO	Dr. Gadallah has nothing to disclose.
Rajesh K. Gupta, MBBS	Dr. Gupta has nothing to disclose.
Sunil Sheth, MD	Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Christopher M. Goshgarian, MD	Dr. Goshgarian has nothing to disclose.
Jeffrey M. Chavin, MD, FAAN	Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Jean-Dominique Gallezot	The institution of Jean-Dominique Gallezot has received research support from Intra-cellular Therapies, Inc.. The institution of an immediate family member of Jean-Dominique Gallezot has received research support from Cerevel.
Vishal Shah, MBBS, FAAN	Dr. Shah has nothing to disclose.
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Alexis D. Boro, MD	Dr. Boro has nothing to disclose.
Mitchel Williams, MD	No disclosure on file
Husnu Efendi, MD	The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Mohammad H. El-Ghanem, MD	Dr. El-Ghanem has nothing to disclose.
Farinaz Safavi, MD, PhD	The institution of Dr. Safavi has received research support from NMSS/ABF.
Farwa Ali, MD	Dr. Ali has nothing to disclose.
Joel N. Phillips, DO, FAAN	Dr. Phillips has nothing to disclose.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Anza B. Memon, MD, FAAN	Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Julia M. Henry, MD	No disclosure on file
Rahul Shah, MBBS	Dr. Shah has nothing to disclose.
Carlos G. Romo, MD	Dr. Romo has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Hyunjin Kim, MD	Dr. Kim has nothing to disclose.
J.V. Mahendra, MD	Dr. Mahendra has nothing to disclose.
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Pawel Tacik, MD	The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, Anavex Life Sciences Corp. The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, AbbVie Germany, Boston Scientific Medical Technology, Medtronic. Dr. Tacik has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Merz Therapeutics, Ipsen Pharma.
Michael Soileau, MD, FAAN	The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. Dr. Soileau has a non-compensated relationship as a Past President with Texas Neurological Society that is relevant to AAN interests or activities.
Glynnis Zieman, MD, MPH, FAAN	Dr. Zieman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Football League.
Juliana VanderPluym, MD	Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.
Zhimin Xu, MD, PhD	Dr. Xu has nothing to disclose.
Steven Zeiler, MD, PhD	Dr. Zeiler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Legal firms. The institution of Dr. Zeiler has received research support from Rose Hill. Dr. Zeiler has received intellectual property interests from a discovery or technology relating to health care.
Tiffany Braley, MD	Dr. Braley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluestar BioAdvisors. The institution of Dr. Braley has received research support from NIH. The institution of Dr. Braley has received research support from PCORI. The institution of Dr. Braley has received research support from National Multiple Sclerosis Society.
Danielle A. Becker, MD	Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Lynn Liu, MD, FAAN	Dr. Liu has nothing to disclose.
Gogi Kumar, MD	Dr. Kumar has nothing to disclose.
Kara Stavros, MD, FAAN	Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Rhode Island Medical Society.
Aimee Luat, MD	Dr. Luat has nothing to disclose.
Justin M. Nolte, MD	Dr. Nolte has nothing to disclose.
Paul B. Ferguson, MD, FAAN	Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Sunita N. Misra, MD	Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Sotiris G. Mitropanopoulos, MD	Dr. Mitropanopoulos has nothing to disclose.
Angeliki Vgontzas, MD	Dr. Vgontzas has nothing to disclose.
Olga R. Thon, MD	Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Thon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Shareena A. Rahman, MD	Dr. Rahman has nothing to disclose.
Tamara Strohm, MD	Dr. Strohm has nothing to disclose.
Tamara B. Kaplan, MD, FAAN	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has or had stock in Cogentis Therapeutics.Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Monique Anderson, MD, PhD	Dr. Anderson has nothing to disclose.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Francisco Rocha	Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Suhas Gangadhara, MD	Dr. Gangadhara has nothing to disclose.
Robert Starke	Robert Starke has nothing to disclose.
Eiji Kitamura	Eiji Kitamura has nothing to disclose.
Yiyun Huang	Yiyun Huang has nothing to disclose.
Carolyn Fredericks, MD	The institution of Dr. Fredericks has received research support from Alzheimer's Association. The institution of Dr. Fredericks has received research support from National Institute on Aging.
Justine K. Chan, MD	Dr. Chan has nothing to disclose.
Navdeep Sangha, MD	Dr. Sangha has nothing to disclose.
Marc Kamin, MD	Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Doris G. Leung, MD	The institution of Dr. Leung has received research support from US Department of Defense. The institution of Dr. Leung has received research support from Fulcrum Therapeutics. The institution of Dr. Leung has received research support from ML Bio Solutions, Inc.. The institution of Dr. Leung has received research support from Sarepta Therapeutics. The institution of Dr. Leung has received research support from Cumberland Pharmaceuticals. The institution of Dr. Leung has received research support from FibroGen Inc.. The institution of Dr. Leung has received research support from Astellas Pharma. The institution of Dr. Leung has received research support from University of Kansas Medical Center Research Institute. The institution of Dr. Leung has received research support from Pfizer, Inc.. The institution of Dr. Leung has received research support from Harmony Biosciences. The institution of Dr. Leung has received research support from Edgewise Therapeutics. The institution of Dr. Leung has received research support from F. Hoffmann-La Roche AG. The institution of Dr. Leung has received research support from Asklepios BioPharmaceutical, Inc.. The institution of Dr. Leung has received research support from Avidity Biosciences. The institution of Dr. Leung has received research support from Virginia Commonwealth University. The institution of Dr. Leung has received research support from Seattle Children's Hospital.
Andrew Zillgitt, DO	Dr. Zillgitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Zillgitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifescience.
Michael Wang, MD	Dr. Wang has nothing to disclose.
Chantal Roy-Hewitson, MD	Dr. Roy-Hewitson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Dr. Roy-Hewitson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Mahesh Chikkannaiah, MD	Dr. Chikkannaiah has nothing to disclose.
Eyal Y. Kimchi, MD, PhD	The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
Jennifer V. Robblee, MD	Dr. Robblee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. An immediate family member of Dr. Robblee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Scottsdale Providence. The institution of Dr. Robblee has received research support from Eli Lilly. The institution of Dr. Robblee has received research support from AbbVie. The institution of Dr. Robblee has received research support from Barrow Neurological Institute. Dr. Robblee has received publishing royalties from a publication relating to health care. Dr. Robblee has received publishing royalties from a publication relating to health care.
Stephen A. Johnson, MD	The institution of Dr. Johnson has received research support from ALS Association.
Sami Fam	Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
Melanie Boly, MD	Dr. Boly has nothing to disclose.
Angelica M. Lee, DO	Dr. Lee has nothing to disclose.
Jesse Thon, MD	An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Jaclyn E. Jacobi, MD	Dr. Jacobi has nothing to disclose.
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Jacob C. Rube, MD	Dr. Rube has nothing to disclose.
Jessica A. Sagen, MA	Ms. Sagen has nothing to disclose.
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Eric Engebretson	Mr. Engebretson has nothing to disclose.
Asli Tuncer	No disclosure on file
Franck G. Amyot, PhD	Dr. Amyot has nothing to disclose.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Stefan Sillau	Stefan Sillau has nothing to disclose.
Giulio Tononi	Giulio Tononi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delix. Giulio Tononi has stock in Intrinsic powers. The institution of Giulio Tononi has received research support from Darpa nih.
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Charles E. Niesen, MD	The institution of Dr. Niesen has received research support from Brain Foundation. Dr. Niesen has received intellectual property interests from a discovery or technology relating to health care.
Filippo Brighina, MD	Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
Sean T. Pauzauskie, MD	Dr. Pauzauskie has stock in Neurable. The institution of Dr. Pauzauskie has received research support from Colorado Office of Economic Development and International Trade.
Jenny J. Feng, MD	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Kristina R. Patterson, MD, PhD	Dr. Patterson has received personal compensation for serving as an employee of Amgen. Dr. Patterson has stock in Amgen.
Michael Popovich, MD	Dr. Popovich has nothing to disclose.
CARLOS MAURICIO M. MILLAN, MD	Dr. Millan has nothing to disclose.
Eric J. Seachrist, MD	Dr. Seachrist has or had stock in Medtronic.Dr. Seachrist has or had stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Ahmed Negida, MD, PhD	Dr. Negida has nothing to disclose.
Nathanael J. Lee, MD, PhD	Dr. Lee has nothing to disclose.
Nara Michaelson, MD	The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Rafid Mustafa, MD	Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Mustafa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PicnicHealth. Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Mustafa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon Biosciences.
Andrea L. Schneider, MD, PhD	Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Lars Bergmann, MD	Dr. Bergmann has received personal compensation for serving as an employee of Abbvie. Dr. Bergmann has or had stock in Abbvie.
Shannon M. LaBoy, MD	Dr. LaBoy has nothing to disclose.
Daniel Gams Massi, Jr., MD	The institution of Dr. Gams Massi has received research support from Academie de Recherche et d'Enseignement Supérieur, Belgique. The institution of Dr. Gams Massi has received research support from World Federation of Neurology. An immediate family member of Dr. Gams Massi has received research support from International Brain Research Organisation. Dr. Gams Massi has received personal compensation in the range of $500-$4,999 for serving as a Faculty with International Parkinson and Movement Disorder Society. Dr. Gams Massi has received personal compensation in the range of $500-$4,999 for serving as a Trainee with TALENTS Program.
Mina Lobbous, MD	Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Pharmaceuticals . Dr. Lobbous has received publishing royalties from a publication relating to health care.
Natasha Hameed, MD	Dr. Hameed has nothing to disclose.
Vaishnavi L. Vaidyanathan, MD	Dr. Vaidyanathan has nothing to disclose.
Aaron Zelikovich, MD	Dr. Zelikovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Viet-Huong Nguyen, PharmD, MPH, MS	Dr. Nguyen has nothing to disclose.
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Dana A. Sugar, MD	Dr. Sugar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Taha Nisar, MD	Dr. Nisar has nothing to disclose.
Shervin Badihian, MD	Dr. Badihian has nothing to disclose.
Tomoko Okamoto	Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma G.K.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teijin Pharma Limited.. The institution of Tomoko Okamoto has received research support from Alexion Pharma G.K.. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. The institution of Tomoko Okamoto has received research support from UCB Japan Co., Ltd. The institution of Tomoko Okamoto has received research support from Biogen Japan Ltd.. The institution of Tomoko Okamoto has received research support from Chugai Pharmaceutical Co., Ltd.. The institution of Tomoko Okamoto has received research support from Mitsubishi Tanabe Pharma Corporation. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Angelo Torrente	Mr. Torrente has nothing to disclose.
Ronald Go	Ronald Go has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Aaron Kaat	Aaron Kaat has received personal compensation for serving as an employee of Northwestern University. Aaron Kaat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kaat Psychometric and Statistic Consulting.
Maher Arabi, MD	Dr. Arabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin .
Fei Han	Fei Han has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Fei-Fei Zhai	Fei-Fei Zhai has nothing to disclose.
Pratit D. Patel, MD	Dr. Patel has nothing to disclose.
Katelyn C. Bird, MD	Dr. Bird has nothing to disclose.
Andrew Christiana, MD	Dr. Christiana has nothing to disclose.
Iris Martinez	Iris Martinez has nothing to disclose.
Magnus Spangsberg Boesen, MD	Dr. Spangsberg Boesen has nothing to disclose.
Dipali P. Nemade, MD	Dr. Nemade has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Daniel M. Schachter, MD	Dr. Schachter has nothing to disclose.
Tatyana R. Gitlevich, MD	Dr. Gitlevich has nothing to disclose.
Lokesh Saini, DM	Dr. Saini has nothing to disclose.
Bradley Shane, MD	Dr. Shane has nothing to disclose.
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Robert J. Rudock II, MD	Dr. Rudock has nothing to disclose.
Jonathan D. Zurawski, MD	The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Kon Chu	Kon Chu has nothing to disclose.
Joseph T Nguyen	Joseph T Nguyen has nothing to disclose.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Yonatan Serlin, MD	Dr. Serlin has nothing to disclose.
Pavnit Kukreja, PharmD	Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Zhiyv Niu, PhD, FACMG	Zhiyv Niu has nothing to disclose.
Michal Obrzut	Michal Obrzut has nothing to disclose.
Muhammad Adeel Saleemi, MBBS	The institution of Dr. Saleemi has received research support from NIH.
Filip Bergquist	The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
James V. Nguyen, MD, MEd	Dr. Nguyen has nothing to disclose.
Reyna M. Duron, MD	No disclosure on file
Matthew Koster	The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rigel. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Matthew Koster has received research support from Sobi.
Said Shukri, MD	Dr. Shukri has nothing to disclose.
Daniel Garbin Di Luca, MD	Dr. Garbin Di Luca has nothing to disclose.
Louise Klebanoff, MD	Dr. Klebanoff has nothing to disclose.
Tove Henriksen, MD	Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nordic infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for convatec. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nordic Infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia.
Mihaela A. Simu, MD, PhD	Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis PHarma . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Romania. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson &Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofy Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson&Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ewopharma A G. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Michelle D. DeJesus Brazitis, MD	Dr. DeJesus Brazitis has nothing to disclose.
Evelyn K. Shih, MD, PhD	Dr. Shih has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Shih has received personal compensation for serving as an employee of SK Life Science, Inc.
Shumei Man, MD, PhD	No disclosure on file
James B. Lewin, PharmD	Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Tanu Garg, MD	Dr. Garg has nothing to disclose.
Edith Graham, MD	Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Graham has received research support from F. Hoffman-La Roche Ltd. The institution of Dr. Graham has received research support from Novartis.
Preeta Gupta, MD	Preeta Gupta, MD has nothing to disclose.
Philippe-Antoine Bilodeau, MD	Dr. Bilodeau has or had stock in Roche. The institution of Dr. Bilodeau has received research support from Alexion Pharmaceuticals. The institution of Dr. Bilodeau has received research support from Department of Defense. Dr. Bilodeau has received research support from Canadian Institutes of Health Research. The institution of Dr. Bilodeau has received research support from Ann Theodore Foundation. Dr. Bilodeau has received research support from The MOG Project.
Yaowaree L. Leavell, MD	Dr. Leavell has nothing to disclose.
Rhaisa Castrodad- Molina, MD	Dr. Castrodad- Molina has nothing to disclose.
Sydni Cole, MD	Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Shuvro Roy, MD	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Roy has received research support from The Siegel Rare Neuroimmune Association.
Nazanin Kiapour, MD	Dr. Kiapour has nothing to disclose.
Ruth Andrea Salazar Camelo, MD	Dr. Salazar Camelo has nothing to disclose.
Christos J. Petropoulos, PhD	Dr. Petropoulos has received personal compensation for serving as an employee of Labcorp-Monogram Biosciences. Dr. Petropoulos has stock in Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Aimen Vanood, MD	Dr. Vanood has nothing to disclose.
Michlene Passeri, MD	Dr. Passeri has nothing to disclose.
Angeliki Filippatou, MD	Dr. Filippatou has nothing to disclose.
Giuseppina Pilloni, PhD	Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
Daniel Chasman, PhD	Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Daniel Chasman has received research support from Pfizer. Daniel Chasman has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Chenna, PhD	Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences. Dr. Chenna has or had stock in LabCorp.
Zi-Yue Liu	Zi-Yue Liu has nothing to disclose.
Samantha Banks, MD	Dr. Banks has nothing to disclose.
Jason Yoon, MD	Dr. Yoon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Anastasia Vishnevetsky, MD	The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Robert A. Rook	Mr. Rook has nothing to disclose.
Nancy A. Mcnamara, MD	Dr. Mcnamara has nothing to disclose.
Soon-Tae Lee, MD, PhD	Prof. Lee has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Piehealthcare. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salted. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Prof. Lee has received research support from Roche. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Jagannadha R. Avasarala, MD, PhD, FAAN	Dr. Avasarala has received personal compensation in the range of $10,000-$49,999 for serving as a Expert analyst with DOJ.
Deborah Holder, MD	Dr. Holder has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova.
Anahit C. Mehrabyan, MD	Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UVB. Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from American Academy of Neurology.
Eric C. Strong, MD	Dr. Strong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Ka Loong K. Au, MD	Dr. Au has nothing to disclose.
Thomas E. Ragole, MD	The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. The institution of Dr. Ragole has received research support from Alexion Pharmaceuticals.
Charles D. McCane	Mr. McCane has nothing to disclose.
Lukasz Milanowski, MD	Dr. Milanowski has nothing to disclose.
Michael Nahhas, MD	Dr. Nahhas has nothing to disclose.
Ashley M. Paul, MD	Dr. Paul has nothing to disclose.
Frederick Bassal, DO	Dr. Bassal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MARAbio.
Robert Vassallo	Robert Vassallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Robert Vassallo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Rion. Robert Vassallo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Robert Vassallo has stock in Rion LLC. The institution of Robert Vassallo has received research support from NIH. The institution of Robert Vassallo has received research support from DOD. Robert Vassallo has received intellectual property interests from a discovery or technology relating to health care.
Sarbesh Tiwari	Sarbesh Tiwari has nothing to disclose.
Bruna de Freitas Dias, MD	Dr. Dias has nothing to disclose.
Henk-Andre A. Kroon, MD, MBA	Dr. Kroon has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Kroon has stock in Annexon Biosciences.
Allan George	Mr. George has nothing to disclose.
Anil Shinde	Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
Carlos Kamiya-Matsuoka, MD	Dr. Kamiya-Matsuoka has nothing to disclose.
Hee Jae Jung, MD	Dr. Jung has nothing to disclose.
Alex Lublin	No disclosure on file
Ramakrishna Nirogi, PhD	Dr. Nirogi has nothing to disclose.
Pradeep Jayarajan, PhD	Pradeep Jayarajan, PhD has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan, PhD has or had stock in Suven Life Sciences.Pradeep Jayarajan, PhD has received intellectual property interests from a discovery or technology relating to health care.
Satish Jetta	Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
Vinod Goyal	Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
Daniel Gonzalez, MD	Dr. Gonzalez has nothing to disclose.
Grant Turek, MD	Dr. Turek has nothing to disclose.
Barrie L. Zerwic, MD	Dr. Schmitt has nothing to disclose.
Takahisa Mikami, MD	Dr. Mikami has nothing to disclose.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Salima Brillman, MD	The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cala Health. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. The institution of Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for USWorldMeds. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acadia. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for USWorld Meds. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Jethro Hu, MD	Dr. Hu has nothing to disclose.
Sai L. Shankar, PhD, FAAN	Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Mohammed A. Alshammari, MBBS	Dr. Alshammari has nothing to disclose.
Ian Walker, MD	Dr. Walker has nothing to disclose.
Parashar Koirala, MD, MBBS	Dr. Koirala has nothing to disclose.
Nazire P. Acar Ozen, MD	Dr. Acar Ozen has nothing to disclose.
Yihui Goh, MBBS	Dr. Goh has nothing to disclose.
Peter Q. Mai, MD	Dr. Mai has nothing to disclose.
Joaquim J. Ferreira	The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial, Neurocrine, AbbVie, Biogen and Lundbeck. The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, AbbVie, BIAL, Biogen, Lundbeck . The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, BIAL, Nordic Infucare, ONO and SK Chemicals.
Yoonhyuk Jang, MD, PhD	Mr. Jang has nothing to disclose.
Wakiro Sato	Wakiro Sato has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Wakiro Sato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma. Wakiro Sato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma.
Aidan Mullan	Aidan Mullan has nothing to disclose.
David Acero-Garces, MD	Dr. Acero-Garces has nothing to disclose.
Abbey Staugaitis	Abbey Staugaitis has nothing to disclose.
Olga Fermo, MD	Dr. Fermo has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier .
Rebecca DiBiase, MD	Dr. DiBiase has nothing to disclose.
Kyle R. Marden, MD	Dr. Marden has nothing to disclose.
Nilton Custodio Capunay, MD, FAAN	Dr. Custodio Capunay has nothing to disclose.
Brian M. Sauer, MD	The institution of Dr. Sauer has received research support from Annexon, Inc.. The institution of Dr. Sauer has received research support from Patient Centered Outcomes Research Center via Mayo Clinic. The institution of Dr. Sauer has received research support from Argenx. The institution of Dr. Sauer has received research support from NINDS & Amgen, Inc.. The institution of Dr. Sauer has received research support from Bristol Myers Squibb; Janssen Pharmaceutical Companies of Johnson & Johnson. The institution of Dr. Sauer has received research support from Genetech Hoffmann-La Roche. The institution of Dr. Sauer has received research support from UCB Biopharma SRL. Dr. Sauer has a non-compensated relationship as a Advisory Board Member, Neuroscience Advisor with Donor Alliance, Inc. that is relevant to AAN interests or activities.
Julian Thomas, MD	Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Ghazal Banisadr, PhD	Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Alexa Dessy, MD	Dr. Dessy has nothing to disclose.
Behnam Sabayan, MD, PhD, MSc, FAHA	The institution of Dr. Sabayan has received research support from NIH. The institution of Dr. Sabayan has received research support from Lilly .
Brian Emmert, Jr., MD	Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zynx. Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Hester Visser	Hester Visser has received personal compensation for serving as an employee of Amneal Pharmaceuticals LLC. Hester Visser has received stock or an ownership interest from Amneal Pharmaceuticals LLC.
Kimberly O'Neill, MD	Dr. O'Neill has nothing to disclose.
Yensea M. Costas Encarnacion, MD	Dr. Costas Encarnacion has nothing to disclose.
Karishma A. Popli, MD, MBE	The institution of Dr. Popli has received research support from American Academy of Neurology.
Namita Patel, MD	Dr. Patel has nothing to disclose.
Maya M. Ramy, MD	Miss Ramy has nothing to disclose.
Emma J. Orozco, MD	Dr. Orozco has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD	Dr. Al-Sabbagh has nothing to disclose.
Chetna Dengri, MD	Dr. Dengri has a non-compensated relationship as a Trainee board member with Neurology Education Journal Editorial Board that is relevant to AAN interests or activities.
Bhrugun Anisetti, MBBS	Dr. Anisetti has nothing to disclose.
Tracy Ming-Chun Yu, MD	Dr. Yu has nothing to disclose.
Ting-Yi Lin, MD	Dr. Lin has nothing to disclose.
Rebecca Salky	Rebecca Salky has nothing to disclose.
Steven Friedman	Steven Friedman has nothing to disclose.
Surendra Dasari	Surendra Dasari has nothing to disclose.
Sean Stern	Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Vijay Benade	Vijay Benade has nothing to disclose.
Erika Abramson	Erika Abramson has nothing to disclose.
Nicholas Belviso, PhD, PharmD	Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Clara Takarabe	Ms. Takarabe has nothing to disclose.
Caroline Crooms, MD, MPH	Dr. Crooms has nothing to disclose.
Arth Pahwa, MD, MBA	Dr. Pahwa has nothing to disclose.
Judy Diep, MD	Dr. Diep has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics .
Vinay Suresh, MBBS	Dr. Suresh has nothing to disclose.
David Plante	David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
Douglas R. Wilcox, MD, PhD	Dr. Wilcox has nothing to disclose.
Teresa Steininger	Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Fiifi Duodu, MD	Dr. Duodu has nothing to disclose.
Clare M. Lambert, MD	Dr. Lambert has nothing to disclose.
María Cedeño-Bruzual, MD	Dr. Cedeño-Bruzual has nothing to disclose.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Hyunah Choi, MD	Dr. Choi has nothing to disclose.
David F. Aguillon, Sr.	No disclosure on file
David Matuskey, MD	Dr. Matuskey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Eleisver. The institution of Dr. Matuskey has received research support from Abbvie.
Saketh Annam, MBBS	Dr. Annam has nothing to disclose.
Yanghong Yang, MD	Dr. Yang has nothing to disclose.
Margarita Fedorova, MD	Dr. Fedorova has nothing to disclose.
Saisree Ravi, MD	Dr. Ravi has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS	Dr. Pasya has nothing to disclose.
Clarence Wade	Clarence Wade has nothing to disclose.
Jose F. Ortega Tola, MD	Dr. Ortega Tola has nothing to disclose.
Mary Penckofer, MD	Ms. Penckofer has nothing to disclose.
Shayan Marsia, MBBS	Dr. Marsia has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Lakshmi Priya Lalitha, MD	Dr. Priya Lalitha has nothing to disclose.
Laura Fonseca	Laura Fonseca has nothing to disclose.
Klevest Gjini	Klevest Gjini has nothing to disclose.
Alan Pan	Alan Pan has nothing to disclose.
Wenxin Li	Mrs. Li has nothing to disclose.
Shweta Kalita, MD	Dr. Kalita has nothing to disclose.
Ram Kinker Mishra, PhD	Dr. Mishra has received personal compensation for serving as an employee of BioSensics LLC.
Resmi Gupta	Resmi Gupta has nothing to disclose.
Ashkan Vaziri, PhD	Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Brandon Yee	Brandon Yee has received personal compensation for serving as an employee of Labcorp. Brandon Yee has stock in Lacborp.
Brittany Krzyzanowski, PhD	Dr. Krzyzanowski has nothing to disclose.
Shayna Pehel	Ms. Pehel has nothing to disclose.
Jiyuan Hu	Jiyuan Hu has nothing to disclose.
Nitin Ramanujam Chakravarthula, MBBS	Dr. Chakravarthula has nothing to disclose.
Sophie Steeland	Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx.
Gabriela Romanow	Gabriela Romanow has nothing to disclose.
Anna Sosa	Anna Sosa has nothing to disclose.
Shiwen Wu	No disclosure on file
Marie Bentsen	Marie Bentsen has received personal compensation for serving as an employee of Novo Nordisk.
Jana Podhorna	Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.
Eva Klinman, MD, PhD	The institution of Dr. Klinman has received research support from Longer Life Foundation. The institution of Dr. Klinman has received research support from NIH.
Soo Hyun Ahn, MD	Dr. Ahn has nothing to disclose.
Luis Brusco, MD	Dr. Brusco has nothing to disclose.
Andrew Wolf, MD	The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Wolf has received research support from Genentech. The institution of Dr. Wolf has received research support from Rocky Mountain MS Center. The institution of Dr. Wolf has received research support from Michael J. Fox Foundation. The institution of Dr. Wolf has received research support from Sanofi. The institution of Dr. Wolf has received research support from Alexion. The institution of Dr. Wolf has received research support from Novartis. The institution of Dr. Wolf has received research support from TG Therapeutics. The institution of Dr. Wolf has received research support from BMS. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received personal compensation in the range of $0-$499 for serving as a Speaker with Rocky Mountain MS Center. Dr. Wolf has a non-compensated relationship as a Board Member with Autoimmune Neurology Research Consortium that is relevant to AAN interests or activities.
Marti Jimenez Mausbach	Marti Jimenez Mausbach has received personal compensation for serving as an employee of Novo Nordisk. Marti Jimenez Mausbach has stock in Novo Nordisk.
Mohamed Derhab, MD, MBBCH	Dr. Derhab has nothing to disclose.
Marisa Whalen	Marisa Whalen has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Stefanie Cappucci, MD	Dr. Cappucci has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer .
Peter Johannsen, MD	Dr. Johannsen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Johannsen has or had stock in Novo Nordisk.
Melanie G. Taylor, MD	Dr. Taylor has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Taylor has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ashley Wabnitz, MD	The institution of Dr. Wabnitz has received research support from NIH.
Mostafa Hotait, MD	Dr. Hotait has nothing to disclose.
Jenny Hua, DO	Dr. Hua has nothing to disclose.
Youwei Lin	No disclosure on file
Karthik N. Rajasekaran, PhD	Dr. Rajasekaran has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Sahla El Mahdaoui, MD	Dr. El Mahdaoui has received personal compensation in the range of $500-$4,999 for serving as a Speaker's honoraria with Merck.
Jude Banihani, MD	Dr. Banihani has nothing to disclose.
Jason T. Schick, DO	Dr. Schick has nothing to disclose.
Hakinya Karra	Hakinya Karra has nothing to disclose.
Manmeet P. Kaur, MD	Dr. Kaur has nothing to disclose.
Reena Bastin, MD	Dr. Bastin has nothing to disclose.
Krima Patel, DO	Dr. Patel has nothing to disclose.
Nishel Y. Kothari, MBBS	Dr. Kothari has nothing to disclose.
Yousef A. Hawas	Mr. Hawas has a non-compensated relationship as a Faculty with American Academy of Neurology Institution (AANI); NeuroBytes: Medical Students Series that is relevant to AAN interests or activities.
Richard E Carson	The institution of Richard E Carson has received research support from Cerevel. The institution of Richard E Carson has received research support from Pfizer.
Mario Yepez, MD	Dr. Yepez has nothing to disclose.
Stephanie R. Knight, NP	Ms. Knight has nothing to disclose.
Sena Destan Bunul	Sena Destan Bunul has nothing to disclose.
Meha Prabhu	Miss Prabhu has nothing to disclose.
Serkan Demir, MD	Dr. Demir has nothing to disclose.
Johnnie Turner	The institution of Mr. Turner has received research support from American Academy of Neurology.
Wendy Tsai, MD	Dr. Tsai has nothing to disclose.
Soren K. Christensen, MD	Mr. Christensen has nothing to disclose.
Mariel Kalkach Aparicio, MD	Mariel Kalkach Aparicio, MD has nothing to disclose.
Kyle Kaneko, DO	Dr. Kaneko has nothing to disclose.
Audrey Huang	Miss Huang has nothing to disclose.
Bradley G. Ong, MD	The institution of Dr. Ong has received research support from American Academy of Neurology. The institution of Dr. Ong has received research support from American Headache Society. Dr. Ong has received personal compensation in the range of $0-$499 for serving as a Expert Witness with Chandler Advocacy. Dr. Ong has a non-compensated relationship as a Editorial Board Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Ong has a non-compensated relationship as a Contributor with Neurology Minute that is relevant to AAN interests or activities.
Shih-Syuan Wang, MD	Dr. Wang has nothing to disclose.
Hira Chouhdry, MD	Ms. Chouhdry has nothing to disclose.
Marcus Milani	Mr. Milani has nothing to disclose.
Sanjana Javalkar	Sanjana Javalkar has nothing to disclose.
Lau Thygesen	No disclosure on file
Ashutosh K. Gupta	Mr. Gupta has nothing to disclose.
Emilie Schou	Emilie Schou has nothing to disclose.
Melita Cacic Hribljan	Melita Cacic Hribljan has nothing to disclose.
Amit Ahituv	Ms. Ahituv has nothing to disclose.
Muhammad Khalid, MD	Dr. Khalid has nothing to disclose.
Kaitlyn Piotrowski	Miss Piotrowski has nothing to disclose.
Jay Ryu	Jay Ryu has nothing to disclose.
Gaurav Goyal	Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Recordati. Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Gaurav Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Electra.
Julio Sartori-Valinotti	Julio Sartori-Valinotti has nothing to disclose.
Aishwarya Ravindran	Aishwarya Ravindran has nothing to disclose.
Jason Young	Jason Young has nothing to disclose.
N. Nora Bennani	No disclosure on file
Maheen Kalwar, MBBS	Dr. Kalwar has nothing to disclose.
Tiffany A. Eatz, MD	Dr. Eatz has nothing to disclose.
Rashad G. Mohamed, MBBS	Dr. Mohamed has nothing to disclose.
Alfred Peter Born	Alfred Peter Born has nothing to disclose.
Ryan Rilinger	Mr. Rilinger has nothing to disclose.
ZL Liaquat	ZL Liaquat has nothing to disclose.
Hafiz M. Maaz	Mr. Maaz has nothing to disclose.
Karen Rech	Karen Rech has nothing to disclose.
Jithma Abeykoon	Jithma Abeykoon has nothing to disclose.
Faranak Ebrahimian Saadabad	Mr. Ebrahimian Saadabad has nothing to disclose.
Ahmed Abbas	Ahmed Abbas has nothing to disclose.
Lucia Belen Varela	Lucia Belen Varela has nothing to disclose.
Brandon S. Wright	Mr. Wright has nothing to disclose.
Michelle You	Ms. You has nothing to disclose.
Reiko Saika	Reiko Saika has nothing to disclose.
Timothy Ko	Timothy Ko has nothing to disclose.
Sahdev S. Baweja	Mr. Baweja has nothing to disclose.
Rebecca Hill	Rebecca Hill has nothing to disclose.
Eisha Tur. Raazia	Eisha Tur. Raazia has nothing to disclose.
Hannah Littel	Hannah Littel has nothing to disclose.
MEKALA GUNASEKARAN	MEKALA GUNASEKARAN has nothing to disclose.
Paul Gravel	Paul Gravel has nothing to disclose.
Muhammad Sohaib, MBBS	Mr. Sohaib has nothing to disclose.
Hossam T. Ali, MD	Dr. Ali has nothing to disclose.
Guzide Ayse Erdemir	Miss Erdemir has nothing to disclose.
Matthew Ridder	Matthew Ridder has nothing to disclose.
Varsha Penumalee	Varsha Penumalee has nothing to disclose.
Shreya Arun	Shreya Arun has nothing to disclose.
Julie Buring	Julie Buring has nothing to disclose.
Brinda Sevak	Brinda Sevak has nothing to disclose.
Kelly Picchione	Dr. Picchione has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Picchione has stock in Biohaven Pharmaceuticals.
Akshay Sharma	Akshay Sharma has nothing to disclose.
Khadija Alam	Khadija Alam has nothing to disclose.
Su Yee Mon	Su Yee Mon has nothing to disclose.
Matthew Grabowski	Matthew Grabowski has nothing to disclose.
Lynn Resnick	Lynn Resnick has received personal compensation for serving as an employee of Biohaven. Lynn Resnick has stock in Biohaven. Lynn Resnick has received intellectual property interests from a discovery or technology relating to health care.
Nadine Azmy	No disclosure on file
Steven Dworetzky	Dr. Dworetzky has received personal compensation for serving as an employee of Biohaven. Dr. Dworetzky has or had stock in Biohaven.Dr. Dworetzky has received intellectual property interests from a discovery or technology relating to health care.
Muaz Ali, MD	Dr. Ali has nothing to disclose.
Lydia Guo	Ms. Guo has a non-compensated relationship as a Board of Directors with National Alzheimer's Buddies that is relevant to AAN interests or activities.
Joseph Sisto	Joseph Sisto has nothing to disclose.
Karen Connor	Karen Connor has received personal compensation in the range of $5,000-$9,999 for serving as a Research Consultant with Mount Sinai.
Anna Eltvedt	Anna Eltvedt has nothing to disclose.
Maria Jose Miranda	Maria Jose Miranda has nothing to disclose.
Peter Uldall	Peter Uldall has nothing to disclose.
Jordan Galbraith	Ms. Galbraith has nothing to disclose.
Daniela Riveros Acosta, MD	Dr. Riveros Acosta has nothing to disclose.
Liam Townley, MD	Dr. Townley has nothing to disclose.
Syed H. Inam, MD	Dr. Inam has nothing to disclose.
Avi Singh Gandh, MD	Dr. Gandh has nothing to disclose.
Dustin Cavida	Mr. Cavida has received personal compensation for serving as an employee of Amgen. Mr. Cavida has stock in Amgen.
Bruna Leles Vieira de Souza, MD	Miss Leles Vieira de Souza has nothing to disclose.
Mikaela D. Camacho Olalla, MD	Dr. Camacho Olalla has nothing to disclose.
Tabish W. Siddiqui	Mr. Siddiqui has nothing to disclose.
Raqshan W. Siddiqui	Ms. Siddiqui has nothing to disclose.
Nirbha Ghurye, MBBS	Dr. Ghurye has nothing to disclose.
Jon Rosenberg, MD	Dr. Rosenberg has nothing to disclose.
Sohaila Fatima	Sohaila Fatima has nothing to disclose.
Shiza Siddiqui	Shiza Siddiqui has nothing to disclose.
Syed Ijlal Ahmed, MD, MBBS	Dr. Ahmed has nothing to disclose.
Pichatorn Suppakitjanusant, MD	Pichatorn Suppakitjanusant, MD has nothing to disclose.
Lauren Hinkley	Miss Hinkley has nothing to disclose.
Manaal Salman	Miss Salman has nothing to disclose.
Shreya Chalapalli	Ms. Chalapalli has nothing to disclose.
Jason Becker, MD	Mr. Becker has nothing to disclose.
Jinyuan Liu, MD	Dr. Liu has nothing to disclose.
Mirjana Maletic-Savatic, MD, PhD	Dr. Maletic-Savatic has nothing to disclose.
Kathleen A. Murray, MD	Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint .
Avantika Singh, MD	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell.
Naman D. Shah, MD	Dr. Shah has nothing to disclose.
Naser Haj Aissa, MBBS	Dr. Haj Aissa has nothing to disclose.
Atakan Selte, MD	Dr. Selte has nothing to disclose.
Jenna L. Miller, MD	Dr. Miller has nothing to disclose.
Asli Buyukkurt, MD	Dr. Buyukkurt has nothing to disclose.
Andreu Vilaseca-Jolonch, MD	Dr. Vilaseca-Jolonch has received research support from Fundación Martín Escudero.
Edwina L. Luna Rodríguez, MD	Dr. Luna Rodríguez has nothing to disclose.
Oreoluwa E. Morakinyo, MBBS	Dr. Morakinyo has nothing to disclose.
Sabrina M. Lora, MD	Miss Lora has nothing to disclose.
Helena Brigas, PhD	Dr. Brigas has received personal compensation for serving as an employee of BIAL.
Munther Queisi, MD	Dr. Queisi has nothing to disclose.
Regina Kurapova, MD	Ms. Kurapova has nothing to disclose.
Nicholas Briski, MD	Dr. Briski has nothing to disclose.
Nishitha Bujala, MBBS	Dr. Bujala has nothing to disclose.
Kole Sedlack, MD	Dr. Sedlack has nothing to disclose.
Shrinjay A. Vyas, MD	Dr. Vyas has nothing to disclose.
Thamer S. Alhowaish, MD	Dr. Alhowaish has nothing to disclose.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Hanns Lochmuller, MD, FAAN	Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CCRM. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Canada Inc. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KYE Pharma. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lochmuller has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precision. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Robert P. Bowser, PhD	An immediate family member of Dr. Bowser has received personal compensation for serving as an employee of nVector, Inc.. Dr. Bowser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma USA. Dr. Bowser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Therapeutics. Dr. Bowser has or had stock in nVector.Dr. Bowser has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Jinsy Andrews, MD, FAAN	Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
Gerald Pfeffer, MD, PhD	Dr. Pfeffer has received research support from Canadian Institutes of Health Research.
Megan Donohue, MD	Dr. Donohue has nothing to disclose.
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has or had stock in Angle Therapeutics.Dr. Johnson has or had stock in Juvena Therapeutics.Dr. Johnson has or had stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Jane Larkindale, PhD	Dr. Larkindale has received personal compensation for serving as an employee of PepGen.
Johanna Hamel, MD	Dr. Hamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals.
Giovanna Manzano, MD	Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Jean-Denis Brisson, MD	Dr. Brisson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Brisson has received research support from Pharnext, Harmony biosciences, PepGen.
Mahsa Khayat-Khoei, MD	The institution of Dr. Khayat-Khoei has received research support from The National MS Society of America, for Fellowship Award.
Charles Esenwa, MD	Dr. Esenwa has nothing to disclose.
Lynsey Lakin, NP	Ms. Lakin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Ms. Lakin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Ms. Lakin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ms. Lakin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. The institution of Ms. Lakin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Ms. Lakin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Ms. Lakin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Ms. Lakin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Ms. Lakin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Jordi Diaz-Manera	Jordi Diaz-Manera has nothing to disclose.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Thurman M. Wheeler, MD	Dr. Wheeler has nothing to disclose.
Julian Grosskreutz	Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
James B. Lilleker, MBChB	Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro.
Nupur Lala, MD	Dr. Lala has nothing to disclose.
Christopher Gilbert, MD	Dr. Gilbert has nothing to disclose.
Manasvi Gupta	Dr. Gupta has nothing to disclose.
Venkata Sai Manikant Sanikommu	Venkata Sai Manikant Sanikommu has received personal compensation for serving as an employee of University Of Miami.
Marjan Sepassi	Dr. SEPASSI has received personal compensation for serving as an employee of Clene Nanomedicine .
Samuel J. Steuart	Mr. Steuart has nothing to disclose.
Alexander Vorobyev, MD	Dr. Vorobyev has nothing to disclose.
Arthur V. Gribachov, MD	Dr. Gribachov has nothing to disclose.
Marina Santos De Sousa, MD	Dr. Santos De Sousa has nothing to disclose.
Apoorva Vedula, MBBS	Miss Vedula has nothing to disclose.
Sunaina Rao, MD	Dr. Rao has nothing to disclose.
Vishnu V. Byroju, MD	Dr. Byroju has nothing to disclose.
Simon Allard, PhD	Dr. Allard has received personal compensation for serving as an employee of Amneal.
Sai Krishna Vallamchetla, MBBS	Mr. Vallamchetla has nothing to disclose.
Fahim Barmak, MD	Dr. Barmak has nothing to disclose.
Marie Tan, MD	Dr. Tan has nothing to disclose.
Sara Lee, MD	Dr. Lee has nothing to disclose.
Mona Avanaki, MD	Dr. Avanaki has nothing to disclose.
Julia L. Bassell, MD	Dr. Bassell has nothing to disclose.
Taleen Shahrigian, DO	Dr. Shahrigian has nothing to disclose.
Jamil Numan, MD	Dr. Numan has nothing to disclose.
Miguel F. Gago, MD, PhD	Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon.
Steven Everett	Mr. Everett has nothing to disclose.
Marina Vilardo	Miss Vilardo has nothing to disclose.
Aswathi Sajeendran, MD	Dr. Sajeendran has nothing to disclose.
Omar Elmandouh, MD	Dr. Elmandouh has nothing to disclose.
Neha Sudarshan	Miss Sudarshan has nothing to disclose.
Stephanie Castro Turbi, MD	Dr. Castro Turbi has nothing to disclose.
Soo Jean Shin	Ms. Shin has nothing to disclose.
Mumen H. Halabi	Mr. Halabi has nothing to disclose.
Hassan K. Salamatullah, Sr.	Mr. Salamatullah has nothing to disclose.
Sharath Chandra Anne, MBBS	Mr. Anne has nothing to disclose.
Pranav J. Mehta	Mr. Mehta has nothing to disclose.
Sarika Mutyala, MBBS	Dr. Mutyala has nothing to disclose.
Md Mostafizur Rahman, MBBS, MS	Dr. Rahman has nothing to disclose.
Melanie Duran, MD	Ms. Duran has nothing to disclose.
Stephan A. Mayer	No disclosure on file
Arman Cakar	Dr. Cakar has nothing to disclose.
Malini Sagar	Malini Sagar has nothing to disclose.
Noboru Imai	Noboru Imai has received personal compensation for serving as an employee of Sawai . Noboru Imai has received personal compensation for serving as an employee of Daiichi Sankyo, Eli Lilly, Otsuka, and Amgen. Noboru Imai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sawai. Noboru Imai has received personal compensation in the range of $1,000,000+ for serving on a Speakers Bureau for Daiichisankyo, Otsuka, Eli-Lilly, AbbVie, Amgen.
Shravani Khisti	Ms. Khisti has nothing to disclose.
Sheharyar Raashid, MD	Sheharyar Raashid, MD has nothing to disclose.
Ana Leticia Fornari Caprara, MD	Dr. Fornari Caprara has nothing to disclose.
Muhammad Tayyab Muzaffar Chaychi, MD	Muhammad Tayyab Muzaffar Chaychi, MD has nothing to disclose.
Moaz E. Abouelmagd, MD	Dr. Abouelmagd has nothing to disclose.
Ariel Sacknovitz, Medical Student	Mr. Sacknovitz has nothing to disclose.
Jad El Ahdab, MD	Dr. El Ahdab has nothing to disclose.
Aishwarya J, MD	Ms. J has nothing to disclose.
Arkansh Sharma	Mr. Sharma has nothing to disclose.
Ang Shen	The institution of Miss Shen has received research support from National Natural Science Foundation of China.
Hamid Abuwarda	Mr. Abuwarda has nothing to disclose.
Ritika Patel	Miss Patel has nothing to disclose.
Praveen Nandha Kumar Pitchan Velammal, MBBS	Dr. Pitchan Velammal has nothing to disclose.
Andy Jiang, BS	Mr. Jiang has nothing to disclose.
Adeena Jamil, MBBS	Dr. Jamil has nothing to disclose.
Abdelfattah Arafa, MBBS	Dr. Arafa has nothing to disclose.
Roaa Zayat, MD	Dr. Zayat has nothing to disclose.
Leonardo J. Cardoso, MS	Mr. Cardoso has nothing to disclose.
Asami Moriya, MD	Dr. Moriya has nothing to disclose.
Rose Jeppesen, MD, PhD	Dr. Jeppesen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Jeppesen has stock in Novo Nordisk.
Mohsen Rastkar, MD	Mr. Rastkar has nothing to disclose.
Mohammad Naseem, MBBS	Dr. Naseem has nothing to disclose.
Sai Shivani Chirag, MS	Miss Chirag has nothing to disclose.
Veera Raghava Chowdary Palacharla, Scientist	Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care.
Santosh Pandey, MVSc, DABT	Mr. Pandey has nothing to disclose.
Ramkumar S, Chief Scientist	Mr. S has nothing to disclose.
Alexa E. Walter, PhD	Dr. Walter has nothing to disclose.
Abdul Rasheed Mohammed, PhD	Mr. Mohammed has nothing to disclose.
Lotte B. Knudsen, DMSc	Dr. Knudsen has stock in Novo Nordisk. Dr. Knudsen has received intellectual property interests from a discovery or technology relating to health care.
Renny Abraham, PhD	Mr. Abraham has nothing to disclose.
YOON HEE SHIN	Ms. SHIN has nothing to disclose.
Hui Li	Dr. Li has nothing to disclose.
Tomasz Chmiela, MD	Dr. Chmiela has nothing to disclose.
Dayoung Seo, RN	Miss Seo has nothing to disclose.
Chengqian Li, MD, PhD	Dr. Li has nothing to disclose.
Eris Spirollari, BA	Mr. Spirollari has nothing to disclose.
Mohammad Munim Zahoor, MD	Mr. Zahoor has nothing to disclose.
Ahmed R. Harb	Mr. Harb has nothing to disclose.
Tim Friede, PhD	Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RECARDIO. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi Sankyo. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BiosenseWebster. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enanta. Prof. Friede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO Therapeutics. Prof. Friede has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Fresenius Kabi Deutschland GmbH.
Dulari Gupta, MD, MBBS	Dr. Gupta has nothing to disclose.
Matthew R. Baker, PhD	Dr. Baker has nothing to disclose.
Francisco A. Mendez, Sr., MD	Dr. Mendez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Menarini.
Jenny Y. Park, PharmD, MS	Dr. Park has received personal compensation for serving as an employee of Amgen Inc.. Dr. Park has or had stock in Amgen Inc..
Lixin Gong, MS	Ms. Gong has nothing to disclose.
Kelly Fisher	Miss Fisher has nothing to disclose.
Kassu Mehari Beyene, PhD	Dr. Beyene has nothing to disclose.
Amatun Noor Prapty, MS	Miss prapty has nothing to disclose.
Christopher Beauvil	Mr. Beauvil has nothing to disclose.
Willy Munyao, PhD	Dr. Munyao has nothing to disclose.
Matteo Ruggiu, PhD	Dr. Ruggiu has nothing to disclose.
Megan Tessmer, RN	Mrs. Tessmer has nothing to disclose.
Kai Guo, MD, PhD	Dr. Guo has nothing to disclose.
Yishang Huang, research data anlayst	Miss Huang has nothing to disclose.
Jamie Sullivan, MPH	Ms. Sullivan has received personal compensation for serving as an employee of EveryLife Foundation for Rare Diseases. An immediate family member of Ms. Sullivan has received personal compensation for serving as an employee of Takeda. Ms. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Policy Advisor with COPD Foundation.
Sweta Sahu	Dr. Sahu has nothing to disclose.
Yong Yu, PhD	Dr. Yu has received research support from National Institutes of Health (NIH).
Ashleeashlee J. Olsenolsen	Miss Olsenolsen has nothing to disclose.
Rylee Cole	Miss Cole has nothing to disclose.
Ashvath A. Pillai, Student	Mr. Pillai has nothing to disclose.
Omnia Samy El-Sayed, MD	Dr. Samy El-Sayed has nothing to disclose.
Niluckshi Pitigala, NP	Mrs. Pitigala has nothing to disclose.
Alvin Ong, PharmD	Dr. Ong has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Ong has stock in Xenon Pharmaceuticals.
Aryan Malhotra	Mr. Malhotra has nothing to disclose.
Tirath Patel	Mr. Patel has nothing to disclose.
Alyssa Cairns, PhD	Dr. Cairns has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Cairns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
Amna M. Ali, BA	Ms. Ali has nothing to disclose.
Zhaonan Sun, PhD	Dr. Sun has received personal compensation for serving as an employee of Biogen. Dr. Sun has stock in Biogen.
Muhammad Junaid, MBBS	Dr. Junaid has nothing to disclose.
Momen S. Syaj, Sr., MD	Dr. Syaj has nothing to disclose.
Safaa Hassan, PhD	Dr. Hassan has nothing to disclose.
Shaimaa A. Elaidy, MD	Dr. Elaidy has nothing to disclose.
sanghui bang, RN	Mr. bang has nothing to disclose.
Yangsean Choi, MD, PhD	Dr. Choi has nothing to disclose.
Hanaa M. AboShereida, PhD	Dr. AboShereida has nothing to disclose.
James Bena, MS	Mr. Bena has nothing to disclose.
Hadeer Hafez, MD	Dr. Hafez has nothing to disclose.
Abdelrhman S. mohamed, MBBS	Dr. mohamed has nothing to disclose.
Isaac Thorman, ScM	Mr. Thorman has nothing to disclose.
Mallika Gopalkrishnan, MBBS	Dr. Gopalkrishnan has nothing to disclose.
Pearse Morris, kjsdfkshd	Ms. Morris has nothing to disclose.
Dhiraj M. Dhane, Sr., PhD	Dr. Dhane has nothing to disclose.
Abeer H. Mandoor, Jr., MBBS	Ms. Mandoor has nothing to disclose.
Joerg Holenz, PhD	Mr. Holenz has received personal compensation for serving as an employee of BIAL. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL RD Investments. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAl Portela SA. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL Biotech . Mr. Holenz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Mr. Holenz has stock in Astra Zeneca. Mr. Holenz has received intellectual property interests from a discovery or technology relating to health care.
Josephine Volovetz, MD	Dr. Volovetz has nothing to disclose.
Riya Palkar	Miss Palkar has nothing to disclose.
Marie Omeara, Pharmacist	Ms. Omeara has nothing to disclose.
Fien Gistelinck	Mrs. Gistelinck has nothing to disclose.
Fien Verhamme, PhD	Dr. Verhamme has received personal compensation for serving as an employee of argenx. Dr. Verhamme has stock in argenx.
Raquel Costa, PharmD, SpLM	Dr. Costa has nothing to disclose.
Jesus Loreto, Caregiver	Mr. Loreto has nothing to disclose.
Waleed N. Ibrahim, MD	Dr. Ibrahim has nothing to disclose.
Chris Turner, MD, PhD	Dr. Turner has received personal compensation for serving as an employee of Vertex Pharmaceuticals . Dr. Turner has received personal compensation for serving as an employee of Dyne Therapeutics . Dr. Turner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmacueticals. Dr. Turner has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Turner Enterprises . The institution of Dr. Turner has received research support from Lupin .
lynkyung choi, PhD	Dr. choi has nothing to disclose.
JIN HEE KIM, PhD	Dr. KIM has nothing to disclose.
EUNSEON JEONG	Miss JEONG has nothing to disclose.
In-Hye Jang	In-Hye Jang has nothing to disclose.
Hongbo Liu	The institution of Hongbo Liu has received research support from China.
Bo-Ra Seo	Bo-Ra Seo has nothing to disclose.
Arielle Lehman, MD	Dr. Lehman has received publishing royalties from a publication relating to health care.
Chad Ruoff, MD	Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . The institution of Dr. Ruoff has received research support from Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer with CME lectures .
Macala Lafrentz	Macala Lafrentz has nothing to disclose.
Michael Devlin	Mr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for The Sumaira Foundation.
Kristin Heerlein	Ms. Heerlein has received personal compensation for serving as an employee of argenx. Ms. Heerlein has received personal compensation for serving as an employee of JNJ. Ms. Heerlein has or had stock in argenx.Ms. Heerlein has or had stock in JNJ.
Deborah A. Nichols, MS	Ms. Nichols has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Nichols has stock in Jazz Pharmaceuticals.
Austin Rynders	Austin Rynders has received personal compensation for serving as an employee of Clene Nanomedicine. Austin Rynders has stock in Clene Nanomedicine. The institution of Austin Rynders has received research support from NIH.
Jacob Evan	Jacob Evan has received personal compensation for serving as an employee of Clene Nanomedicine Inc..
Jeremy Evan, PA	Mr. Evan has received personal compensation for serving as an employee of Clene Nanomedicine Inc.
Alan Hartford, PhD	Mr. Hartford has received personal compensation for serving as an employee of Clene Nanomedicine, Inc.. The institution of Mr. Hartford has received research support from NIH.
Michael Hotchkin	Mr. Hotchkin has received personal compensation for serving as an employee of Clene Nanomedicine, Inc. Mr. Hotchkin has stock in Clene Nanomedicine, Inc.
Sonja Blum, MD, PhD	Dr. Blum has nothing to disclose.
Mahsa Ghajarzadeh, MD	Dr. Ghajarzadeh has nothing to disclose.
Somil Bhushan	Mr. Bhushan has nothing to disclose.
Alexander Junxiang Chen	Mr. Chen has nothing to disclose.
Rolake Feyisetan	Ms. Feyisetan has nothing to disclose.
Mulan Jiang	Ms. Jiang has nothing to disclose.
Aneesh Kamath	Mr. Kamath has nothing to disclose.
Teresa Howard	Miss Howard has nothing to disclose.
Mohamed M. Ali, MD	Dr. Ali has nothing to disclose.
Staci P. Hunter, DO	Dr. Hunter has nothing to disclose.
Adam Morehead, MD	Dr. Morehead has nothing to disclose.
Lana Sharba, MD	Dr. Sharba has nothing to disclose.
Nana Boakye Agyeman Badu, MD	Dr. Agyeman Badu has nothing to disclose.
Robert Kim, MD, PhD	Dr. Kim has nothing to disclose.
CARL A. HASFORD, MD	Dr. HASFORD has nothing to disclose.
Beyza Canik, MD	Dr. Canik has nothing to disclose.
Salvatore Citro, MD	Dr. Citro has nothing to disclose.
Shivi Kumar	Miss Kumar has nothing to disclose.
Vincent Wang	Mr. Wang has nothing to disclose.
Joseph Sun	An immediate family member of Mr. Sun has received personal compensation for serving as an employee of Suninflam Inc.. An immediate family member of Mr. Sun has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Suninflam Inc.. An immediate family member of Mr. Sun has or had stock in Suninflam Inc.. An immediate family member of Mr. Sun has or had stock in TrueBinding Inc.. An immediate family member of Mr. Sun has received intellectual property interests from a discovery or technology relating to health care. Mr. Sun has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Mr. Sun has received intellectual property interests from a discovery or technology relating to health care.
Habib E. Akouri	Mr. Akouri has nothing to disclose.
Jaydevsinh Dolia, MD	Dr. Dolia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. The institution of Dr. Dolia has received research support from Emory Medical Care Foundation.
Subhash H. Shah, MD	Dr. Shah has nothing to disclose.
Jerald H. Simmons, MD	No disclosure on file
Sayed Z. Naqvi, MD	Dr. Naqvi has nothing to disclose.
Michael C. Schubert, PhD, PT, FAPTA	Michael C. Schubert, PT, MS has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANPT.
Abdolreza Esfahanizadeh, MD	Dr. Esfahanizadeh has nothing to disclose.
Theodore L. Katner, MD	Dr. Katner has nothing to disclose.
Simon Y. Kayyal, MD	Dr. Kayyal has nothing to disclose.
Amy L. Patterson, MD	Dr. Patterson has nothing to disclose.
Bijal Patel	Dr. Patel has nothing to disclose.
Andre Galis, MD	Dr. Galis has nothing to disclose.
Dean Delgado, DO	Dr. Delgado has nothing to disclose.
Laya Rajan, PhD	Dr. Rajan has nothing to disclose.
Maria Pia Grant Tejada, MD	Dr. Grant Tejada has nothing to disclose.
Robin L. Jack, MD	Dr. Jack has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Brenda V. Ropero, MD	Dr. Ropero has nothing to disclose.
Alizah A. Patterson, MD	Dr. Patterson has nothing to disclose.
Jerrica R. Farias, NP	Ms. Farias has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Ms. Farias has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Biophrama. Ms. Farias has received personal compensation in the range of $500-$4,999 for serving as a Consultant for POCN. Ms. Farias has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Ms. Farias has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Ms. Farias has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB Biopharma. Ms. Farias has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Ms. Farias has a non-compensated relationship as a Member with AANEM AAP Education Commitee that is relevant to AAN interests or activities. Ms. Farias has a non-compensated relationship as a Member with NEALS APP Committee that is relevant to AAN interests or activities.
Saga Johansson	Saga Johansson has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Saga Johansson has stock in Jazz pharmaceuticals.
David Benhuri, MD	Dr. Benhuri has nothing to disclose.
Minna Choi, MD	Dr. Choi has nothing to disclose.
Joshua M. Adams, MD, PhD	Dr. Adams has nothing to disclose.
Ramsha Siddiqui, MBBS	Dr. Siddiqui has nothing to disclose.
Bita Naderi, PharmD	Dr. Naderi has received personal compensation for serving as an employee of Amneal Pharmaceuticals . Dr. Naderi has stock in Johnson & Johnson .
Erick D. Martinez, MD	Dr. Martinez has nothing to disclose.
Moritz Niederschweiberer	No disclosure on file
Douglas R. Nordli III, MD	Dr. Nordli has nothing to disclose.
Amaya De La Pena, MD	Dr. De La Pena has nothing to disclose.
Haiwen Chen, MD, PhD	The institution of Dr. Chen has received research support from NINDS. The institution of Dr. Chen has received research support from SRNA.
Aileen Hsi, MD	Dr. Hsi has nothing to disclose.
Sangri Kim, MD	Dr. Kim has nothing to disclose.
Efthalia Angelopoulou	The institution of Mrs. Angelopoulou has received research support from Hellenic Foundation Research and Innovation.
Philip Webber, PhD	Dr. Webber has received personal compensation for serving as an employee of SK Life Science Inc.
Lisle W. Blackbourn IV, MD	Dr. Blackbourn has nothing to disclose.
Curtis A. Amankwah, MD	Dr. Amankwah has nothing to disclose.
Anthony J. DiCesare, DO	Dr. DiCesare has nothing to disclose.
Henry A. Herrera, MD	Dr. Herrera has nothing to disclose.
Gurunathan Srinivasan	Mr. Srinivasan has nothing to disclose.
Quynh Kieu	Quynh Kieu has nothing to disclose.
Shyam Patel, DO	Dr. Patel has nothing to disclose.
Susan Alford, PhD	Dr. Alford has received personal compensation for serving as an employee of Novo Nordisk, Inc.. Dr. Alford has stock in Novo Nordisk.
Chinmayi Balusu, MPH	Miss Balusu has received personal compensation for serving as an employee of Dana Foundation.
Ahmad Abu Qdais, MD	Dr. Abu Qdais has nothing to disclose.
Bala Vignesh Kalyanasundaram	Mr. Kalyanasundaram has nothing to disclose.
Ahmed A. Mohamed, MD	Dr. Mohamed has nothing to disclose.
Sanghyo Lee, MD	Dr. Lee has nothing to disclose.
Jacob Farris, MD	Dr. Farris has nothing to disclose.
Sanjana Nayak, MD	Dr. Nayak has nothing to disclose.
Nilofar Vora	Miss Vora has nothing to disclose.
Mohammad M. Assaf	Dr. Assaf has nothing to disclose.
Mabel Waqar	Miss Waqar has nothing to disclose.
Claudia Guerra Hernandez, PA	Ms. Guerra Hernandez has nothing to disclose.
Rachael K. Cundey	Ms. Cundey has nothing to disclose.
Kassem Al Asaad, MBBS	Kassem Al Asaad, MBBS has nothing to disclose.
Clay V. Willis	The institution of Mr. Willis has received research support from Robert C. Byrd Center for Rural Health.
Behnam Sarafpour	Dr. Sarafpour has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Sarafpour has or had stock in Annexon Biosciences.
Robert Araujo Contreras	Mr. Araujo Contreras has nothing to disclose.
Paola V. Oyola	Miss Oyola has nothing to disclose.
Andrew Holley, PhD	Dr. Holley has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Mi Zhou, MD, PhD	Dr. Zhou has nothing to disclose.
Bahar Saber, MD	Dr. Saber has nothing to disclose.
Ayla Barakat, MD	Dr. Barakat has nothing to disclose.
Sapna Shah, MD	Dr. Shah has nothing to disclose.
Aun Syed, DO	Dr. Syed has nothing to disclose.
Erica Wan, MD	Ms. Wan has nothing to disclose.
Yatin Srinivash Ramesh Babu	Mr. Ramesh Babu has nothing to disclose.
Anfal Hamza	Mr. Hamza has nothing to disclose.
HaoYao Guo	Mr. Guo has nothing to disclose.
Hasen H. Aljadani	Mr. Aljadani has nothing to disclose.
Marian A. Javier	Mrs. Javier has nothing to disclose.
Neetu Choudhary IV, PhD	Mrs. Choudhary has received research support from CSIR.
Nidhi M. Patel	Miss Patel has nothing to disclose.
Julia Stephen	Miss Stephen has nothing to disclose.
Bara M. Hammadeh	Mr. Hammadeh has nothing to disclose.
Meghana Chennupati, MBBS	Miss Chennupati has nothing to disclose.
Syeda T. Fatima	Syeda T. Fatima has nothing to disclose.
Lori Hanneman	Lori Hanneman has nothing to disclose.
Monika Rettler, MD	Dr. Rettler has nothing to disclose.
Daniel Isaza Pierotti, MD, MCSO	Dr. Isaza Pierotti has nothing to disclose.
Chen Chen, MD	Dr. Chen has nothing to disclose.
Dechen Samdrup, MD	Dr. Samdrup has nothing to disclose.
Yasmin Minai, BS	Miss Minai has nothing to disclose.
Kanchan Chaudhary, MBBS	Dr. Chaudhary has nothing to disclose.
Rana Faheem U. Khan, MBBS	Dr. Khan has nothing to disclose.
Jose De Los Santos, MD	Dr. De Los Santos has nothing to disclose.
Hemangi Rajpal	Ms. Rajpal has nothing to disclose.
Abdul Eizad Asif	Mr. Asif has nothing to disclose.
Annick Melanie MAGNEROU, MD	Dr. MAGNEROU has nothing to disclose.
Ankit K. Meena, MD	Dr. Meena has nothing to disclose.
Amir Mashni	Mr. Mashni has nothing to disclose.
Malene L. Børresen, MD, PhD	Dr. Børresen has nothing to disclose.
Amalie Klein-Petersen	Miss Klein-Petersen has nothing to disclose.
Charlotte Slavick	Ms. Slavick has nothing to disclose.
Rakhshanda Khan, MBBS	Dr. Khan has nothing to disclose.
Huma Manjra, MD	Ms. Manjra has nothing to disclose.
Eileen Yung, MD	Dr. Yung has nothing to disclose.
Rishu Raj, MBBS	Mr. Raj has nothing to disclose.
Gabriel Martino, MD	Dr. Martino has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Martino has stock in Novo Nordisk. Dr. Martino has stock in Roche. Dr. Martino has stock in Eli Lilly.
Anas Mansour, MD	Dr. Mansour has nothing to disclose.
Mohamed Abdelsalam, MBBS	Dr. Abdelsalam has nothing to disclose.
Syed A. Hussain, MD	Dr. Hussain has nothing to disclose.
Norimitsu Inoue, PhD	Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Prof. Inoue has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Swedish Orphan Biovitrum Japan. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Prof. Inoue has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCBJapan. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Japan. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanwa Kagaku Kenkyusyo . Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Swedish Orphan Biovitrum Japan. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kissei Pharmaceutical. Prof. Inoue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Asahi Kasei Pharma. The institution of Prof. Inoue has received research support from Japan Agency for Medical Research and Development. The institution of Prof. Inoue has received research support from Ministry of Health, Labour and Welfare. The institution of Prof. Inoue has received research support from National Center of Neurology and Psychiatry.
Jenna Boykin, Medical Student	Ms. Boykin has nothing to disclose.
Kathy Piela, PT	Dr. Piela has nothing to disclose.
Gregory Barchard	Mr. Barchard has nothing to disclose.
Amber LaMarca, PT	Dr. LaMarca has nothing to disclose.
Julie J. Keysor, PhD, PT	Prof. Keysor has nothing to disclose.
Federico Bauducco	Mr. Bauducco has received personal compensation for serving as an employee of Spaulding Rehabilitation Hospital.
Anne O'Brien, PT	Ms. O'Brien has nothing to disclose.
Mona Sajed, Ph	Dr. Sajed has nothing to disclose.
Paolo Bonato, PhD	The institution of Dr. Bonato has received research support from NIH. The institution of Dr. Bonato has received research support from NSF. The institution of Dr. Bonato has received research support from DoD.
Ilaria Stewart	Miss Stewart has nothing to disclose.
Caterina Rivera	Ms. Rivera has nothing to disclose.
Amir H. Hegazi, MBBS	Mr. Hegazi has nothing to disclose.
Aditi Agarwal, MBBS	Ms. Agarwal has nothing to disclose.
Alan Morris, PhD	Dr. Morris has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Deyrha Jennifer Mills, MD	Dr. Mills has nothing to disclose.
Amna Zaheer	Miss Zaheer has nothing to disclose.
Zhongrui Yan, MD, PhD	Prof. Yan has nothing to disclose.
Mansoor Iqbal	Mr. Iqbal has nothing to disclose.
Eliza Aisha	Ms. Aisha has nothing to disclose.
Jing Dai, PhD	Dr. Dai has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Mariana Hiromi M. Oku, MD	Dr. Oku has nothing to disclose.
Bismay Mishra	Mr. Mishra has received personal compensation for serving as an employee of Annexon Biosciences. Mr. Mishra has or had stock in Annexon Biosciences.
Kennedy Gerber	Kennedy Gerber has nothing to disclose.
Joaquim Ferreira, MD, PhD	Prof. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial, Biogen, AbbVie, Roche, Stada, Lundbeck, Lilly and Organon. Prof. Ferreira has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Prof. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bial, Biogen, AbbVie, Stada, ONO, Major Pharma, SK Chemicals, Infucare.
Ashwini Chityala, MD	Dr. Chityala has nothing to disclose.
Arbaz Hassan, MBBS	Mr. Hassan has nothing to disclose.
Babak Amerian-Williams	Mr. Amerian-Williams has nothing to disclose.
Sindhu V. Potlapalli	Ms. Potlapalli has nothing to disclose.
Tony Alocious	Mr. Alocious has nothing to disclose.
Chelsey Fix-King	Ms. Fix-King has nothing to disclose.
MUHAMMAD REHMAN IFTIKHAR, MBBS	Dr. IFTIKHAR has nothing to disclose.
Michelle Oliveira Fernandes, PhD	Ms. Oliveira Fernandes has received personal compensation for serving as an employee of AbbVie. Ms. Oliveira Fernandes has stock in AbbVie.
Shradha P. Kakde, MBBS	Dr. Kakde has nothing to disclose.
Christina A. Pacak, PhD	Dr. Pacak has received personal compensation in the range of $0-$499 for serving as a Consultant for LifeSciences Consultants. An immediate family member of Dr. Pacak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurogene. An immediate family member of Dr. Pacak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. An immediate family member of Dr. Pacak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics. An immediate family member of Dr. Pacak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MLAB Biosciences. An immediate family member of Dr. Pacak has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. An immediate family member of Dr. Pacak has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Pacak has received research support from Sarepta Therapeutics. The institution of Dr. Pacak has received research support from Regenerative Medicine MN. The institution of Dr. Pacak has received research support from Greg Marzolf Jr Foundation. The institution of Dr. Pacak has received research support from NIH. The institution of Dr. Pacak has received research support from Viljem Julijan Association for Children with Rare Diseases . The institution of an immediate family member of Dr. Pacak has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Pacak has received research support from Centers for Disease Control and Prevention. The institution of an immediate family member of Dr. Pacak has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Pacak has received research support from Food and Drug Administration. The institution of an immediate family member of Dr. Pacak has received research support from National Initiative for Cockayne Syndrome. The institution of an immediate family member of Dr. Pacak has received research support from Greg Marzolf Jr. Foundation. The institution of an immediate family member of Dr. Pacak has received research support from Sarepta Therapeutics. The institution of an immediate family member of Dr. Pacak has received research support from Duchenne UK - PPMD. The institution of Dr. Pacak has received research support from MN Partnership . Dr. Pacak has received intellectual property interests from a discovery or technology relating to health care. Dr. Pacak has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Pacak has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. An immediate family member of Dr. Pacak has a non-compensated relationship as a President (including President Elect and Past President) with Child Neurology Society that is relevant to AAN interests or activities. An immediate family member of Dr. Pacak has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities.
Faseeh Haider, MD, MBBS	Dr. Haider has nothing to disclose.
Nfwama Kawatu	Nfwama Kawatu has nothing to disclose.
David J. Alexander, MS2	Mr. Alexander has nothing to disclose.
Abdul Rehman R. Nasir, MBBS	Mr. Nasir has nothing to disclose.
Yu Cai	Yu Cai has nothing to disclose.
Ahmed Abdelmageed, MBBS	Dr. Abdelmageed has nothing to disclose.
Imran Khan	Imran Khan has nothing to disclose.
Hanna Malik, DO	Hanna Malik, DO has nothing to disclose.
Anjali Goyal	Ms. Goyal has nothing to disclose.
Brenna McCormack, MBBCh	Dr. McCormack has nothing to disclose.
Humna Shahid, MBBS	Miss Shahid has nothing to disclose.
Maryam Saghir, MBBS	Miss Saghir has nothing to disclose.
Dionysia Kontaxopoulou, PhD	Dr. Kontaxopoulou has received personal compensation for serving as an employee of Hellenic Foundation Research and Innovation.
Muhammad Wasi Khan, MBBS	Dr. Khan has nothing to disclose.
Majd Rachid, MD	Dr. Rachid has nothing to disclose.
Revika Singh	Miss Singh has nothing to disclose.
Anna Melina Daniela Eva Luna Bacchetti, MD	Dr. Bacchetti has nothing to disclose.
Pranshi Juneja, DO	Pranshi Juneja has nothing to disclose.
Muhammad Moiz Javed, MD	Dr. Javed has nothing to disclose.
Ayesha Syed	Ms. Syed has received research support from NIH Medical Student Training in Aging Research (MSTAR) Program.
Devesh Pant, PhD	Dr. Pant has nothing to disclose.
Agustin M. Ibañez, PhD	No disclosure on file
Andrew Yoo, PhD	The institution of Dr. Yoo has received research support from Eisai. Dr. Yoo has received intellectual property interests from a discovery or technology relating to health care.
Julian A. Prieto	Mr. Prieto has nothing to disclose.
Maryam Vasefi, PhD	Dr. Vasefi has nothing to disclose.
Mehreen Ali	Miss Ali has nothing to disclose.
Avanteeka Ganguly	Miss Ganguly has nothing to disclose.
Grace L. Fjermedal, Medical Student	Ms. Fjermedal has nothing to disclose.
Angela Liu	Ms. Liu has nothing to disclose.
Huzaifa S. Nawaz, MBBS	Dr. Nawaz has nothing to disclose.
Allison M. LeHanka	Miss LeHanka has nothing to disclose.
Faizan Tariq, MBBS	Dr. Tariq has nothing to disclose.
Maryam Zahra II, MBBS	Miss Zahra has nothing to disclose.
Noorul Hidhaya S, MBBS	Miss S has nothing to disclose.
Alexander P. Gabrielli, PhD	Dr. Gabrielli has nothing to disclose.
Kelsey Williams	Ms. Williams has nothing to disclose.
Kweku Marfo	Mr. Marfo has nothing to disclose.
Sunny Ssu-Yu Chen, Medical Student	Mr. Chen has nothing to disclose.
Peter B. Biney, Bsc	Mr. Biney has nothing to disclose.
Madeleine Brownfield	Ms. Brownfield has nothing to disclose.
Richard H. Fu, Medical Student	Mr. Fu has nothing to disclose.
Qasim Chohdry	Mr. Chohdry has nothing to disclose.
Nikhil Vj, Student	Mr. Vj has nothing to disclose.
RAJIV RADHAKRISHNAN, MD	Dr. RADHAKRISHNAN has received personal compensation for serving as an employee of BMS. The institution of Dr. RADHAKRISHNAN has received research support from Jazz Pharmaceuticals.
Christopher Pittenger, MD, PhD	Dr. Pittenger has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Pittenger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Freedom Biosciences. Dr. Pittenger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB BioPharma. Dr. Pittenger has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for lucid.care. Dr. Pittenger has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mind Therapeutics. Dr. Pittenger has stock in Alco Therapeutics. Dr. Pittenger has stock in Mind Therapeutics. The institution of Dr. Pittenger has received research support from Biohaven Pharmaceuticals. The institution of Dr. Pittenger has received research support from Biohaven Pharmaceuticals. Dr. Pittenger has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittenger has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittenger has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittenger has received publishing royalties from a publication relating to health care. Dr. Pittenger has received publishing royalties from a publication relating to health care.
Ryan Cool	Mr. Cool has nothing to disclose.
Kate Burnes	Ms. Burnes has nothing to disclose.
Omnea Elgendy	Ms. Elgendy has nothing to disclose.
Ezza Bashir, MD	Dr. Bashir has nothing to disclose.
Anas Z. Nourelden, MD	Dr. Nourelden has nothing to disclose.
Muhammad Abdullah, MD	Dr. Abdullah has nothing to disclose.
Dr Pratiksha S. Baliga, MBBS	Dr. Baliga has nothing to disclose.
Kayley Stroupe	Mrs. Stroupe has nothing to disclose.
Lora K. Talley, PhD	Dr. Talley has nothing to disclose.
Waqas Ahmad, MBBS	Mr. Ahmad has nothing to disclose.
Sara Shah, MS	Ms. Shah has nothing to disclose.
Lillian Bower	Ms. Bower has nothing to disclose.
Mohammad Abubakr, BS	Mr. Abubakr has nothing to disclose.
Aasha Patel, Student	Ms. Patel has nothing to disclose.
Barka Sajid, MBBS	Dr. Sajid has nothing to disclose.
Ruyu Shi, PhD	Ms. Shi has nothing to disclose.
April E. Pivonka	Ms. Pivonka has nothing to disclose.
Xingqi Pan	Miss Pan has nothing to disclose.
Elena Quinonez Del Cid, medical student	Ms. Quinonez Del Cid has nothing to disclose.
Joshua E. Lopez, Medical Student	Mr. Lopez has nothing to disclose.
Snigdha Kosuri, MPH	Miss Kosuri has nothing to disclose.
Marcos D. Brea Montes de Oca, MD	Dr. Brea Montes de Oca has nothing to disclose.
Soha Kazmi, Medical Student	Miss Kazmi has nothing to disclose.
Bryce Kassalow, BA	Mr. Kassalow has nothing to disclose.
Neil Nero, MLIS	Mr. Nero has nothing to disclose.
Parinda Ansusinha, MD	Miss Ansusinha has nothing to disclose.
Diego J. Gil Troncoso, MD	Mr. Gil Troncoso has nothing to disclose.
Neha Patil	Miss Patil has nothing to disclose.
Austin G. Li	Mr. Li has nothing to disclose.
Natee Deepan, MD	Mr. Deepan has nothing to disclose.
Saad Tanzeem	Mr. Tanzeem has nothing to disclose.
Eric Freire Alvarez, MD	Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Freire Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esteve. Dr. Freire Alvarez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Neuraxpharm. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orion Pharma. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Freire Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Shivaraj Nallur Somanna, MD	Mr. Nallur Somanna has nothing to disclose.
Syed Mohsin Raza Bukhari, MBBS	Dr. Bukhari has nothing to disclose.
Muhammad Ans, MBBS	Ms. Ans has nothing to disclose.
Elizabeth A. Blalock, Medical Student	Ms. Blalock has nothing to disclose.
Laura Gelfman, MD	The institution of Dr. Gelfman has received research support from NINR. The institution of Dr. Gelfman has received research support from NIA.
Emanuela Santoro, Medical student	Miss Santoro has nothing to disclose.
Rohini K. Chahal, BSA	Ms. Chahal has nothing to disclose.
Sara Zalcgendler, MD	Dr. Zalcgendler has nothing to disclose.
Adivitch Sripusanapan, MD	Dr. Sripusanapan has nothing to disclose.
Hassan Mehdi, MBBS	Dr. Mehdi has nothing to disclose.
Muhammad Salman Sajid, MBBS	Mr. Sajid has nothing to disclose.
Fatima Munir, MBBS	Dr. Munir has nothing to disclose.
Lorenzo Malfer, MD	Dr. Malfer has nothing to disclose.
Deya'a I. Alasmar, MD	Dr. Alasmar has nothing to disclose.
Mohammad Faysel, PhD	Dr. Faysel has nothing to disclose.
Abhigna Mallepally, MBBS	Abhigna Mallepally, MBBS has nothing to disclose.
Aditya Jain, MBBS	Dr. Jain has nothing to disclose.
Arhum Razi	Mr. Razi has nothing to disclose.
Lisbeth Carstensen, PhD	Ms. Carstensen has received personal compensation for serving as an employee of Novo Nordisk A/S. Ms. Carstensen has stock in Novo Nordisk A/S.
Trevor McCutcheon	Mr. McCutcheon has nothing to disclose.
Tina Ting-An Lin, MD	Ms. Lin has nothing to disclose.
Soyoung Youm	Ms. Youm has received personal compensation for serving as an employee of Inventagelab.
Joo Young Cha	Mr. Cha has nothing to disclose.
Soonho Song	Mr. Song has nothing to disclose.
Ju Hee Kim	Ms. Kim has received personal compensation for serving as an employee of Inventagelab.
Sangno Lee	Mr. Lee has nothing to disclose.
Abdullah Obadi, MD	Dr. Obadi has nothing to disclose.
Muhammad S. Raza, Jr., Resident physician	Dr. Raza has nothing to disclose.
Nabeeha Noor, MD	Ms. Noor has nothing to disclose.
Matthew Petruncio	Mr. Petruncio has nothing to disclose.
Huda Memon	Miss Memon has nothing to disclose.
Huong Nguyen, PhD	The institution of Dr. Nguyen has received research support from NIH, PCORI.
Gurleen Kaur, MBBS	Dr. Kaur has nothing to disclose.
Muhammad Talha T. Maqsood, MBBS	Dr. Maqsood has nothing to disclose.
Ahsan Abid, MBBS	Dr. Abid has nothing to disclose.
Sai Alekha Challa	Ms. Challa has nothing to disclose.
Tho Alyazan K. Al-Jabali, MBBS	Dr. Al-Jabali has nothing to disclose.
Aseel Magzoub, MBBS	Dr. Magzoub has nothing to disclose.
Moayad H. Mudawi, MBBS	Dr. Mudawi has nothing to disclose.
Adam E. Ibrahim, MBBS	Dr. Ibrahim has nothing to disclose.
Sabry Babiker Hassan Sayed, MBBS	Dr. Sayed has nothing to disclose.
Aditi Narsinghpura, MBBS	Dr. Narsinghpura has nothing to disclose.
Salwa Sayih, MBBS	Dr. Sayih has nothing to disclose.
Ryan O. Badawi, MBBS	Dr. Badawi has nothing to disclose.
SANKRANTHI SARATH CHANDRA, MBBS	Dr. CHANDRA has nothing to disclose.
YU-CHI CHAO, MD	Dr. CHAO has nothing to disclose.
Dylan M. Belmont-Rausch, PhD	Dr. Belmont-Rausch has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Belmont-Rausch has or had stock in Novo Nordisk.Dr. Belmont-Rausch has or had stock in Viking Therapeutics.Dr. Belmont-Rausch has or had stock in Madrigal Pharmaceuticals.
Shenney Lin, MS-2	Ms. Lin has nothing to disclose.
Elena Hayday	Ms. Hayday has nothing to disclose.
Claire Wu, Student	Ms. Wu has nothing to disclose.
Julianne Mallinger, BS	Miss Mallinger has nothing to disclose.
Mohammad Hassan, MBBS	Dr. Hassan has nothing to disclose.
ALex Glatman, MD	Dr. Glatman has nothing to disclose.
Alexandrea Kilgore-Gomez, BS	Ms. Kilgore-Gomez has nothing to disclose.
Abdullah Durrani, Medical Student	Mr. Durrani has nothing to disclose.
Naser Hamad, Medical Student	Mr. Hamad has nothing to disclose.
Lauren Suh, MD Student	Ms. Suh has nothing to disclose.
Muhammad Saim, MBBS	Mr. Saim has nothing to disclose.
Jason H. Yan, BA	Mr. Yan has nothing to disclose.
Rohini Rana, PhD	Dr. Rana has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Zahava Turner, RDN	Mrs. Turner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia Danone.
Stacey K. Bessone, RD	Ms. Bessone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nutricia North America.
Sophia Hopkins	Miss Hopkins has nothing to disclose.
Ricardo E. Calderón Rivera, BS	Mr. Calderón Rivera has nothing to disclose.
Brad Padilla, MPH	Mr. Padilla has received personal compensation for serving as an employee of Stratevi. The institution of Mr. Padilla has received research support from Xenon Pharmaceuticals Inc. .
Tamanna Dhore	Ms. Dhore has nothing to disclose.
Damyan I. Dekajlo	Mr. Dekajlo has nothing to disclose.
Yinxi Zou, MD, PhD	Dr. Zou has nothing to disclose.
KARTIKA GULATI, MD	Dr. GULATI has nothing to disclose.
Bing Ye, PhD	The institution of Prof. Ye has received research support from NIH.
Katherine L. Schleiss, MPH	Ms. Schleiss has nothing to disclose.
Tiffany Gervasi-Follmar, MPH, CCRP	Mrs. Gervasi-Follmar has nothing to disclose.
Mark K. Farkas, MD, PhD	Dr. Farkas has nothing to disclose.
Atif N. Malik, MD	Dr. Malik has nothing to disclose.
Robert J. Tomlinson	Mr. Tomlinson has stock in Johnson & Johnson.
Ava Panetto	Ms. Panetto has nothing to disclose.
Abigail Keeton	Ms. Keeton has nothing to disclose.
Tina Chai, MD	Dr. Chai has nothing to disclose.
Hussien O. Hussien, MBBS	Dr. Hussien has nothing to disclose.
Grâce Kelly P. Doumbe, MD	Dr. Doumbe has nothing to disclose.
Steven E. Haworth, MS	Mr. Haworth has nothing to disclose.
Aaron Paul	Mr. Paul has nothing to disclose.
Morag Graham, PhD	Dr. Graham has nothing to disclose.
Kijeong Kim, MD	Mr. Kim has nothing to disclose.
Cameron J. Sabet, MD	Mr. Sabet has nothing to disclose.
Weaam Masoud, MD	Dr. Masoud has nothing to disclose.
Bhav Jain, BS	Mr. Jain has received personal compensation for serving as an employee of National Academy of Medicine.
Chloe J. Cohan	Ms. Cohan has nothing to disclose.
Alexander Kaizer, PhD	Dr. Kaizer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telperian Inc. Dr. Kaizer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biodesix, Inc.. Dr. Kaizer has received research support from NIH. Dr. Kaizer has received research support from Cystic Fibrosis Foundation.
Nidhi H. Vadhavekar, MBBS	Dr. Vadhavekar has nothing to disclose.
Matthew A. Kasper, BA	An immediate family member of Mr. Kasper has received personal compensation for serving as an employee of MedPro Group.
Minahil Zaheer, MBBS	Dr. Zaheer has nothing to disclose.
Muhammad Hassan, MBBS	Dr. Hassan has nothing to disclose.
Muneeba umar, MBBS	Dr. umar has nothing to disclose.
Emily Gansert, MD	Dr. Gansert has nothing to disclose.
Ali Zubair, MBBS	Dr. Zubair has nothing to disclose.
Abeera Amir, MD	Dr. Amir has nothing to disclose.
Tugba Ozum Irmak, MD	Mrs. Ozum Irmak has nothing to disclose.
Ria Subramanian	Ms. Subramanian has nothing to disclose.
Danish Ali, MBBS	Dr. Ali has nothing to disclose.
Eshal Saghir, MBBS	Miss Saghir has nothing to disclose.
Manahil Khan, MBBS	Miss khan has nothing to disclose.
Charles N. Bernstein, MD	Dr. Bernstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Eli Lilly, Celltrion, Fresenius-Kabi, Janssen, Ferring, Organon, Pfizer, Takeda,. Dr. Bernstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Eli Lilly, Janssen, Fresenius Kabi, Medtronic,Pfizer, Takeda. The institution of Dr. Bernstein has received research support from Abbvie, Janssen, Pfizer, Celltrion.
Ahmed R. Benchouia	Mr. Benchouia has nothing to disclose.
Anchit Chauhan	Mr. Chauhan has nothing to disclose.
Anshal Vyas	Mr. Vyas has nothing to disclose.
Tejaswin Mariappan, MBBS	Mr. Mariappan has nothing to disclose.
Hilary A. Marusak, PhD	Dr. Marusak has nothing to disclose.
Abigail Biddix, BS	Mrs. Biddix has nothing to disclose.
Avinash Thangirala, MD	Dr. Thangirala has nothing to disclose.
Jordan Poles, MD	Dr. Poles has nothing to disclose.
Andrew Ady, MS	Mr. Ady has nothing to disclose.
Jordan Carbono, MD	Dr. Carbono has nothing to disclose.
Humza Qureshi	Mr. Qureshi has nothing to disclose.
Patricia McGoldrick, NP	Mrs. McGoldrick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for JAZZ. Mrs. McGoldrick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for assertio. Mrs. McGoldrick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stokes. Mrs. McGoldrick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for JAZZ. Mrs. McGoldrick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for neurelis. Mrs. McGoldrick has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for liva nove.
Sarah Crowder, DO	Dr. Crowder has nothing to disclose.
Suchita Mylavarapu, MBBS	Dr. Mylavarapu has nothing to disclose.
Merritt D. Kinon, MD	Dr. Kinon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Globus. Dr. Kinon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanara Medtech. Dr. Kinon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerapedis. Dr. Kinon has stock in Globus.
Alex Wonnaparhown, MD	Dr. Wonnaparhown has nothing to disclose.
Bruno F. Santos, MD	Dr. Santos has received personal compensation for serving as an employee of Bial.
Aleena Sharif, MBBS	Dr. Sharif has nothing to disclose.
Husnain Ahmad, MBBS	Mr. Ahmad has nothing to disclose.
Vincenzo Di Stefano, MD, PhD	Dr. Di Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Andrew H. Lee	Mr. Lee has nothing to disclose.
Shrideavi Murugan, MBBS	Miss Murugan has nothing to disclose.
CAI-YAN LIU	Dr. LIU has nothing to disclose.
Gary J. Luckasen, MD	Dr. Luckasen has nothing to disclose.
Aqsa Adnan, PharmD	Dr. Adnan has nothing to disclose.
Stephanie Cramer, Registered Dietitian	Ms. Cramer has nothing to disclose.
Milo Coffee	Mr. Coffee has nothing to disclose.
John W. Thompson, PhD	Dr. Thompson has nothing to disclose.
Alexei Gonzalez-Estrada, MD	Dr. Gonzalez-Estrada has nothing to disclose.
Mawadda Abdelhai, MD	Miss Abdelhai has nothing to disclose.
Diya Rathi, MBBS	Miss Rathi has nothing to disclose.
Ameer Afzal Khan, Final Year MBBS Student	Mr. Khan has nothing to disclose.
Hadiya Javed, MBBS	Ms. Javed has nothing to disclose.
Erin Mathieu	Miss Mathieu has nothing to disclose.
Robin Ortiz, MD	Dr. Ortiz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCAAN (UCLA-UCSF ACEs Aware Family Resilience Network) and related Adverser Childhood Experiences (ACEs) work. Dr. Ortiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for New York State Trauma-Informed Resource Network Adivosry Board.
Matthew L. Baum, MD, PhD, DPhil	Dr. Baum has received publishing royalties from a publication relating to health care.
Javed Ahamed Cumbum Syed, MBBS	Mr. Cumbum Syed has nothing to disclose.
Umberto Quartetti, MD	Dr. Quartetti has nothing to disclose.
Emma Weizenbaum, PhD	Dr. Weizenbaum has nothing to disclose.
Gloria A. Macalintal, Associate Director	Mrs. Macalintal has nothing to disclose.
Khalid W. Bin Aziz, MBBS	Dr. Bin Aziz has nothing to disclose.
Naciye Guduk Sirvan, MD	Dr. Guduk Sirvan has nothing to disclose.
Nawwaf Alfayez	Dr. Alfayez has nothing to disclose.
Mustafa Ekici, MD	Dr. Ekici has nothing to disclose.
Karen Costenbader, MD, MPH	Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. The institution of Prof. Costenbader has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck. Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Prof. Costenbader has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen/UCB. Prof. Costenbader has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Lupus Foundation of America. Prof. Costenbader has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Rheumatology. The institution of Prof. Costenbader has received research support from NIH. The institution of Prof. Costenbader has received research support from Department of Defense. Prof. Costenbader has received intellectual property interests from a discovery or technology relating to health care. Prof. Costenbader has received publishing royalties from a publication relating to health care.
Dima Mutawe	Ms. Mutawe has nothing to disclose.
Abdulrahman M. Alrasheed, MBBS	Dr. Alrasheed has nothing to disclose.
Tayyaba Malik, Jr., MBBS	Miss Malik has nothing to disclose.
Haran Srinivasan Saravanan, MBBS	Mr. Saravanan has nothing to disclose.
Anjani Mahesh Kumar Cherukuri, MBBS	Dr. Cherukuri has nothing to disclose.
Mayvis Rebeira, PhD	Ms. Rebeira has received personal compensation for serving as an employee of Alexion.
Allison Mitchell	Ms. Mitchell has nothing to disclose.
Mashoor Al Ahammed	Mr. Ahammed has nothing to disclose.
ayse n. bolukcu III	Dr. bolukcu has nothing to disclose.
Ogia A. Sam, Medical student	Miss Sam has nothing to disclose.
GaResia Woods	Miss Woods has nothing to disclose.
Sugapradha Saravanan, BS	Miss Saravanan has nothing to disclose.
Santiago Philibert - Rosas, MD	Dr. Philibert - Rosas has nothing to disclose.
John M. Slopis, MD	Dr. Slopis has nothing to disclose.
Kristen Zuloaga, PhD	Dr. Zuloaga has nothing to disclose.
Carrie R. Muh, MD	Dr. Muh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. Dr. Muh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Muh has received intellectual property interests from a discovery or technology relating to health care.
Catherine Vidano	Ms. Vidano has nothing to disclose.
Victoria Hough	Miss Hough has nothing to disclose.
Anish Saxena	Mr. Saxena has nothing to disclose.
Jude F. Al-Mufti	Miss Al-Mufti has nothing to disclose.
Neema Darabi, BS	Mr. Darabi has nothing to disclose.
Pius O. Ocran	Mr. Ocran has nothing to disclose.
Rebecca Gambatese, MPH	Ms. Gambatese has nothing to disclose.
Amna A. Jalal, MBBS	Dr. Jalal has nothing to disclose.
Somwe Wa Somwe, MD	Dr. Wa Somwe has nothing to disclose.
Katherine R. Schon, MD, PhD	Dr. Schon has nothing to disclose.
Eiichiro Amano, MD, PhD	Dr. Amano has nothing to disclose.
Salma Younas, PhD, PharmD	Miss Younas has nothing to disclose.
Areeba Basaria, MBBS	Dr. Basaria has nothing to disclose.
Marco Catani, MD, PhD	Prof. Catani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Rahman Syed, Medical student	Mr. Syed has nothing to disclose.
Anfal Khan, MBBS	Mr. Khan has nothing to disclose.
Mohsin Ali, MBBS	Dr. Ali has nothing to disclose.
Sanjana Avajigari, MBBS	Miss Avajigari has nothing to disclose.
Muhammad Waleed Imran, MBBS	Mr. Imran has nothing to disclose.
Chirag L Sagar, MBBS	Dr. L Sagar has nothing to disclose.
Ioannis Stamelos, MD	The institution of Mr. Stamelos has received research support from the Hellenic Foundation for Research and Innovation .
Ramya Manojna Hota, MBBS	Dr. Hota has nothing to disclose.
Giovanna Dane, RN	Mrs. Dane has nothing to disclose.
Harshawardhan D. Ramteke, Sr., MBBS	Dr. Ramteke has nothing to disclose.
Lori L. Isom, PhD	Dr. Isom has stock in Abbvie. The institution of Dr. Isom has received research support from NIH. The institution of Dr. Isom has received research support from CURE Epilepsy. The institution of Dr. Isom has received research support from Dravet Syndrome Foundation.
Bhumi D. Patel	Ms. Patel has nothing to disclose.
Ian Ackers, DO, PhD	Dr. Ackers has nothing to disclose.
Syed Faiz Ahmed	Mr. Faiz Ahmed has nothing to disclose.
Silvana B. De Lorenzo, PhD	Dr. De Lorenzo has nothing to disclose.
Muhammad Talha, MBBS	Mr. Talha has nothing to disclose.
Kalliopi Vourou, PhD	The institution of Miss Vourou has received research support from Hellenic Foundation Research Innovation .
Evangelia Smaragdaki, PhD Candidate	The institution of Mrs. Smaragdaki has received research support from Hellenic Foundation Research and Innovation .
Madison Estrela	Miss Estrela has nothing to disclose.
Randy D'Amico, MD	Dr. D'Amico has received personal compensation for serving as an employee of omniscient. Dr. D'Amico has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for omniscient.
Sanwal Sardar Nawaz, MBBS	Mr. Nawaz has nothing to disclose.
Priti Trivedi, PhD	Dr. Trivedi has nothing to disclose.
Ahlanna J. Olson	Ms. Olson has nothing to disclose.
Dhruval Patel, Senior Scientist	Mr. Patel has nothing to disclose.
Ketankumar Gondalia, Senior Principal Scientist	Mr. Gondalia has nothing to disclose.
Cameron J. Brace	Mr. Brace has nothing to disclose.
Grace S. Opong	Ms. Opong has nothing to disclose.
Brady A. Riedner, PhD	Dr. Riedner has received research support from Experimental Therapeutics & Pathophysiology Branch of NIMH.
Carlin A. Beskrone	Mr. Beskrone has nothing to disclose.
Javeria Masood, MBBS	Dr. Masood has nothing to disclose.
Carolyn Valdez, MS	Mrs. Valdez has nothing to disclose.
Tae-Joon Kim, MD, PhD	Dr. Kim has nothing to disclose.
Rahul Gupta, MD, MBBS, PDF	Dr. Gupta has nothing to disclose.
Rana A. Aqeel, Students	Dr. Aqeel has nothing to disclose.
Charly Abi Ghanem, PhD	The institution of Dr. Abi Ghanem has received research support from BrightFocus Foundation.
Matthew S. Dawson, PhD	Dr. Dawson has nothing to disclose.
Chiheng Zhou	Ms. Zhou has nothing to disclose.
Benjamin Weiss	Mr. Weiss has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Apreo Health. Mr. Weiss has stock in Field Meical.
Talha Sajjad, MBBS	Dr. Sajjad has nothing to disclose.
Christine Bonner	Miss Bonner has nothing to disclose.
Anna Smith	Ms. Smith has nothing to disclose.
Daniel Ramos	Mr. Ramos has received personal compensation for serving as an employee of BIAL.
Muhammad Affan, MBBS	Dr. Affan has nothing to disclose.
Shobhan Vachhrajani, MD, PhD	Dr. Vachhrajani has nothing to disclose.
Sergio Della Sala, MD, PhD	Prof. Della Sala has nothing to disclose.
Tushya Mehta, PhD Student	Mr. Mehta has nothing to disclose.
Jinming Zhang, PhD	Dr. Zhang has received personal compensation for serving as an employee of IPSEN BIOPHARMACEUTICALS, INC..
Denise (. YI, PhD	Dr. YI has received personal compensation for serving as an employee of Servier Pharmaceuticals.
Dillan Prasad, MD	Dr. Prasad has nothing to disclose.
Shankar Biswas, MD	Dr. Biswas has nothing to disclose.
Amber Erich	Miss Erich has nothing to disclose.
Kate Deppen	Mrs. Deppen has nothing to disclose.
Olga Demler, PhD	The institution of Dr. Demler has received research support from NIH. The institution of Dr. Demler has received research support from American Heart Association. The institution of Dr. Demler has received research support from Swiss Federal Institute of Technology. Dr. Demler has received personal compensation in the range of $5,000-$9,999 for serving as a DSM board with Kowa Institute.
Noah Sugg	Mr. Sugg has nothing to disclose.
Chao Peng, PhD	The institution of Dr. Peng has received research support from NIH. The institution of Dr. Peng has received research support from MJFF.
Jeffrey Ware, MD	Dr. Ware has nothing to disclose.
Aiman Javed, Jr., MBBS	Miss Javed has nothing to disclose.
Blessy Jacob, Pharm D	Mrs. Jacob has nothing to disclose.
Paolo Alonge, MD	Dr. Alonge has nothing to disclose.
Carlo Cavaliere, MD, PhD	Dr. Cavaliere has nothing to disclose.
Nicole Middaugh, PhD	Dr. Middaugh has nothing to disclose.
Jenny Zhang, OMS II	Miss Zhang has nothing to disclose.
Tariq Alauddin	Mr. Alauddin has nothing to disclose.
Mushk Fatima, MBBS	Dr. Fatima has nothing to disclose.
Tatiana M. Kielty, BS	Miss Kielty has nothing to disclose.
Elizabeth Metzger	Ms. Metzger has received personal compensation for serving as an employee of The Geneva Foundation. Ms. Metzger has received research support from University of Michigan .
Basanta Pathak, MBBS	Dr. Pathak has nothing to disclose.
Yana Said, MD	Dr. Said has nothing to disclose.
Mahtab zafar, MBBS	Dr. zafar has nothing to disclose.
Ayesha Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Brittany Spitznagel, PhD, PharmD	Dr. Spitznagel has nothing to disclose.
Muhammad Atif, MBBS	Dr. Atif has nothing to disclose.
Umama Javed, MBBS	Miss Javed has nothing to disclose.
Swaibah Tariq, MBBS	Miss Tariq has nothing to disclose.
Abdul S. Khan, MBBS	Dr. Khan has nothing to disclose.
MUHAMMAD HARIS AKRAM, MBBS	Dr. AKRAM has nothing to disclose.
Ofelia Cespedes Moreno, MD	Dr. Cespedes Moreno has nothing to disclose.
Samuel A. Mensah, MBChB	Dr. Mensah has nothing to disclose.
Isabel Adkisson, BA	Ms. Adkisson has nothing to disclose.
Rae A. Moreland	Mrs. Moreland has nothing to disclose.
Ahmad Beyh, PhD	Dr. Beyh has nothing to disclose.
Cesar Higgins Tejera, PhD	Mr. Higgins Tejera has nothing to disclose.
Ahmad W. Safi, MD	Dr. Safi has nothing to disclose.
Elizabeth Crevier, MPH	Mrs. Crevier has received personal compensation for serving as an employee of Avalere Health.
Mike Nalls, PhD	An immediate family member of Dr. Nalls has received personal compensation for serving as an employee of Valo Health. The institution of Dr. Nalls has received personal compensation in the range of $1,000,000+ for serving as a Consultant for DataTecnica. Dr. Nalls has stock in Neuron23 and Character Bio. The institution of Dr. Nalls has received research support from US govt, various NPO and Commercial. Dr. Nalls has received intellectual property interests from a discovery or technology relating to health care.
Alexander Komarov, PhD	Dr. Komarov has nothing to disclose.
Magdy H. Shehab, Sr., MD	Dr. Shehab has nothing to disclose.
Lina M. Zapata-Restrepo, MD	Dr. Zapata-Restrepo has nothing to disclose.
J. Nicholas Cochran, PhD	The institution of Dr. Cochran has received research support from NIH. The institution of Dr. Cochran has received research support from Alzheimer's Association. The institution of Dr. Cochran has received research support from Rainwater Charitable Foundation.
Alexis Oddi	Ms. Oddi has nothing to disclose.
Mohamed Ellebedy, MD	Dr. Ellebedy has nothing to disclose.
Kareem Khalefa, MD	Dr. Khalefa has nothing to disclose.
Anjali Patel	Miss Patel has nothing to disclose.
sarah amro, MD	Dr. amro has nothing to disclose.
Sarah C. Hopp, PhD	The institution of Dr. Hopp has received research support from NIH. Dr. Hopp has received personal compensation in the range of $0-$499 for serving as a study section reviewer with NIH. Dr. Hopp has a non-compensated relationship as a executive committee member with Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment that is relevant to AAN interests or activities.
Brinda Palliyana	Ms. Palliyana has nothing to disclose.
Emma Hillis, MSPH	Ms. Hillis has nothing to disclose.
Muhammad T. Moazzam, MS	Mr. Moazzam has nothing to disclose.
Muhammad Tariq, MS	Mr. Tariq has nothing to disclose.
Amanda Jarosik	Ms. Jarosik has nothing to disclose.
Georgios Gakis, MD	Dr. Gakis has nothing to disclose.
Valentina Portera, MD	Miss Portera has nothing to disclose.
Zain Tirmizi	Mr. Tirmizi has nothing to disclose.
Xantippe VanArsdale, MLIS	Ms. VanArsdale has nothing to disclose.
Tommy Kim	Mr. Kim has nothing to disclose.
Avery Buehler	Mr. Buehler has nothing to disclose.
Pabitra Hriday Patra	Dr. Patra has nothing to disclose.
Vicky Chan, PT	Dr. Chan has received personal compensation for serving as an employee of University of California Irvine. Dr. Chan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioniks.
Stefanie Darnley	Ms. Darnley has nothing to disclose.
sydney niesen	Ms. niesen has nothing to disclose.
Elizabeth Brouwer, PhD	Ms. Brouwer has nothing to disclose.
Sharon Elumelu	Ms. Elumelu has nothing to disclose.
Yordanos G. Kifle	Mrs. Kifle has nothing to disclose.
Esther Bonojo	Ms. Bonojo has nothing to disclose.
Liang-Yuan Lin	Miss Lin has received personal compensation for serving as an employee of Johnson & Johnson.
Grace Steward, PhD	Dr. Steward has received personal compensation for serving as an employee of Northwestern University.
Flavio DellAcqua, PhD	Dr. DellAcqua has received personal compensation in the range of $0-$499 for serving as a Consultant for Nordic Imaging Lab. The institution of Dr. DellAcqua has received research support from ACimmune. Dr. DellAcqua has received intellectual property interests from a discovery or technology relating to health care. Dr. DellAcqua has received publishing royalties from a publication relating to health care.
Janet E. Olson, PhD	Dr. Olson has nothing to disclose.
Stefan Prulovic, MD	Mr. Prulovic has nothing to disclose.
Jiwoo Han	Miss Han has nothing to disclose.
Nii Duodu Ologo Djan, MBBS	Mr. Ologo Djan has nothing to disclose.
Martin A. Bruno, PhD	Dr. Bruno has nothing to disclose.
Juan P. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Jay J. Han, MD	Dr. Han has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Han has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Physical Medicine and Rehabilitation.
Juan Carlos Perez Ibarra, PhD	Dr. Perez Ibarra has received research support from George E Hewitt Foundation for Medical Research.
Tom T. Vanasse, PhD	Dr. Vanasse has received personal compensation for serving as an employee of EnsoData.
Raymond D. Rojas	Mr. Rojas has nothing to disclose.
Eunice D. Olajimi	Miss Olajimi has nothing to disclose.
Kian Koh, PhD	Prof. Koh has nothing to disclose.
Wen-Xiang Tsai, PhD	Mr. Tsai has nothing to disclose.
Estefanía Quarteroni, Sr., PT	Mrs. Quarteroni has nothing to disclose.
Jeimy M. Castellanos, MBBS	Dr. Castellanos has nothing to disclose.
LE KANG, PhD	Dr. KANG has nothing to disclose.
Luis Garcia-Fernandez	Mr. Garcia-Fernandez has nothing to disclose.
Ueli Rutishauser, PhD	Dr. Rutishauser has nothing to disclose.
Amelia Tenberg, NP	Mrs. Tenberg has nothing to disclose.
yue wang, MD	Dr. wang has nothing to disclose.
Sindhu Vasireddy, MD	Dr. Vasireddy has nothing to disclose.
Muataz O. Kashbour, MBBS	Dr. Kashbour has nothing to disclose.
Delaney Ryan, MPH	Miss Ryan has nothing to disclose.
Susan S. Cohen, MD	Dr. Cohen has nothing to disclose.
Dhruv U. Goltekar	Mr. Goltekar has nothing to disclose.
Raveen Muzaffer, MBBS	Dr. Muzaffer has nothing to disclose.
Angeliki Pollatou	Dr. Pollatou has received research support from The Geneva Foundation.
Safia Abdemeziem, Jr., MS in Health Informatics	Miss Abdemeziem has nothing to disclose.
Christina Ledbetter, PhD	Dr. Ledbetter has nothing to disclose.
Tomas Mendoza Peña	Mr. Mendoza Peña has nothing to disclose.
Nuttida Rungratsameetaweemana, PhD	Prof. Rungratsameetaweemana has nothing to disclose.
Jacob Thompson	Mr. Thompson has nothing to disclose.
Danush Aditya Munikrishnan, MBBS	Mr. Munikrishnan has nothing to disclose.
Raleigh Sorbonne, Medical Student	Mr. Sorbonne has nothing to disclose.
Sujasha Gupta, PhD	Dr. Gupta has nothing to disclose.
Mallika P. Patel, PharmD	Dr. Patel has nothing to disclose.
Fahad W. Bin Aziz, MBBS	Dr. Bin Aziz has nothing to disclose.
Kashmala Rahl, MBBS	Dr. Rahl has nothing to disclose.
Vikash Ayyappan	Mr. Ayyappan has nothing to disclose.
Awais Qadir	Mr. Qadir has nothing to disclose.
Atsuko Katsumoto, MD, PhD	Dr. Katsumoto has nothing to disclose.
Rudra Pratap Singh, MD	Dr. SINGH has nothing to disclose.
Riya Srivastava	Ms. Srivastava has nothing to disclose.
Christin Kuo, MD	The institution of Dr. Kuo has received research support from NETRF. The institution of Dr. Kuo has received research support from NIH.
Jigar Patel, MD	Dr. Patel has nothing to disclose.
Stefanie D. Piña Escudero, MD	Dr. Piña Escudero has nothing to disclose.
Kendall Lin, BS	Mr. Lin has nothing to disclose.
Tim Dyrby	Prof. Dyrby has nothing to disclose.
Murat Kasap, PhD	Prof. Kasap has nothing to disclose.
Vincent Im	Mr. Im has nothing to disclose.
Nadia Bolognini, PhD	Prof. Bolognini has nothing to disclose.
Bernard K. van der Veer, PhD	Dr. van der Veer has nothing to disclose.
Tipu Sultan, MBBS	Prof. Sultan has nothing to disclose.
amol N. patil, MD	Dr. patil has nothing to disclose.
Haleema Bibi, MBBS	Dr. Bibi has nothing to disclose.
Mohammed A. Alhefdhi, MBBS	Dr. Alhefdhi has nothing to disclose.
Elangovan Krishnan, MBBS, PhD, PGDHM, M Tech	Dr. Krishnan has nothing to disclose.
Karen K. Altomari-Nelson, RN	Mrs. Altomari-Nelson has nothing to disclose.
Shailja Vaghela, MS, MBA, MPH	Miss Vaghela has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Annexon Biosciences.
Amna Iqbal, MBBS	Dr. Iqbal has nothing to disclose.
Nithyanandam Allimuthu, MD	Dr. Allimuthu has nothing to disclose.
Melissa E. Petersen, PhD	Dr. Petersen has nothing to disclose.
Sarah C. Katsandres, MPH	Ms. Katsandres has nothing to disclose.
Kristen Scherrer, PhD	Dr. Scherrer has nothing to disclose.
Michael V. Murphy	Mr. Murphy has nothing to disclose.
Meryem Ay, MD	No disclosure on file
Xiao Jing Wang, MD	Dr. Wang has received publishing royalties from a publication relating to health care.
Justin Desprebiteres, BA	Mr. Desprebiteres has nothing to disclose.
Vaisnavy Govindasamy, MBBS	Dr. Govindasamy has nothing to disclose.
Vincent W. Rogalski III	Mr. Rogalski has nothing to disclose.
Amanda Burgos, MS	Ms. Burgos has nothing to disclose.
samanta diaz menai, MD	Ms. diaz menai has nothing to disclose.
Fan Zhang	Dr. Zhang has nothing to disclose.
Jordan Behn	Mr. Behn has nothing to disclose.
Camila M. Escobar, Sr., MD	Miss Escobar has nothing to disclose.
Khadija Tanvir, MBBS	Dr. Tanvir has nothing to disclose.
Muhammad Hamza Shoaib, MBBS	Mr. Shoaib has nothing to disclose.
Giorgio C. Ricciardiello Mejia	Mr. Ricciardiello Mejia has nothing to disclose.
Brice Calco	Mr. Calco has nothing to disclose.
Christof Karmonik, PhD	Dr. Karmonik has nothing to disclose.
Elena B. Lynott, Research Assistant	Miss Lynott has nothing to disclose.
Erwin T. Cabacungan, MD	Dr. Cabacungan has nothing to disclose.
Gaurie Gunasekaran	Dr. Gunasekaran has nothing to disclose.
Jennifer Harris, RN	Mrs. Harris has nothing to disclose.
Chien-wen J. Choi	Ms. Choi has received personal compensation for serving as an employee of Thermo Fisher Scientific.
Lauren Ruiz	Mrs. Ruiz has received personal compensation for serving as an employee of Institute for Public Health Innovation.
Colton E. Troxel	Mr. Troxel has nothing to disclose.
Indraneel M. Deshpande, MA	Mr. Deshpande has nothing to disclose.
Yusra Rizwan, MBBS	Dr. Rizwan has nothing to disclose.
Sam Beniyel Kalastick Jebadurai, MD	Dr. Kalastick Jebadurai has nothing to disclose.
Brian Ellis	Mr. Ellis has nothing to disclose.
Pavan Raju Kola, MD	Mr. Kola has nothing to disclose.
Esther Tantsis, MBBS, PhD	The institution of Dr. Tantsis has received research support from Cerebral Palsy Alliance Research Institute.
Juan S. Rojas Mendoza, MD, MSc PH	Mr. Rojas Mendoza has received personal compensation for serving as an employee of Charité – University Medicine Berlin.
Sabeeh K. Farooqui, MBBS	Dr. Farooqui has nothing to disclose.
Fatima Awais, MBBS	Dr. Awais has nothing to disclose.
Keenan W. Davis, PhD	Dr. Davis has nothing to disclose.
Ulrike DeMarco, Senior Research Scientist	Ms. DeMarco has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. DeMarco has stock in Biohaven Pharmaceuticals.
Sakina Shaikh	Miss Shaikh has nothing to disclose.
Nitish Khindri	Mr. Khindri has nothing to disclose.
Megan Coghlan, MD	Dr. Coghlan has nothing to disclose.
Mustafa Abdul Kareem, MD	Dr. Abdul Kareem has nothing to disclose.
Sanjana Palakodeti	Sanjana Palakodeti has nothing to disclose.
Maria Fioletova	Mrs. Fioletova has nothing to disclose.
Aidan R. Butler	The institution of Mr. Butler has received research support from American Academy of Neurology.
Holly Hunsberger, PhD	The institution of Dr. Hunsberger has received research support from Ataraxia LLC.
Nikolas A. Melkumyan	Mr. Melkumyan has nothing to disclose.
Lainey Toennies, BS	Mrs. Toennies has nothing to disclose.
Grace Stutzmann, PhD	Dr. Stutzmann has nothing to disclose.
Daniel F. Steinbrenner, PhD	Dr. Steinbrenner has nothing to disclose.
Kameron Kaplan	Mr. Kaplan has nothing to disclose.
Zhifei Wang, PhD	Dr. Wang has nothing to disclose.
Mary Maj, PhD	Dr. Maj has nothing to disclose.
Emma Baker	Ms. Baker has nothing to disclose.
Cliff Eskey, MD, PhD	Dr. Eskey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple law firms in multiple states.
Ashlee M. Webber	Mrs. Webber has nothing to disclose.
Myoung Kim, PhD	Ms. Kim has received personal compensation for serving as an employee of Annexon Biosciences.
David Weaver, PhD	Dr. Weaver has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Weaver has stock in Biohaven Pharmaceuticals. Dr. Weaver has stock in WaveFront Biosciences, L.L.C.. An immediate family member of Dr. Weaver has stock in ION Biosciences.
Lingxin Wang, PhD	Dr. Wang has nothing to disclose.
Jaeyeon Kim	Dr. Kim has nothing to disclose.
Adam N. Mamelak, MD	Dr. Mamelak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Blaze Bioscience. Dr. Mamelak has stock in Blaze Bioscince. The institution of Dr. Mamelak has received research support from NIH.
Karrie A. Lundstrom	Ms. Lundstrom has received personal compensation in the range of $10,000-$49,999 for serving as a reservist with United States Navy.
Hafiz Muhammad Sameer, MBBS	Dr. Sameer has nothing to disclose.
gwenn smith, PhD	Dr. smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Assocation for Geriatric Psychiatry.
Kelly Smith, PhD	Dr. Smith has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Smith has stock in Biohaven Pharmaceuticals.
Muhammad Z. Azhar	Mr. Azhar has nothing to disclose.
Melissa A. Geyer, PhD	Dr. Geyer has received personal compensation for serving as an employee of Sanofi.
Luis Garegnani, PhD, PT	Prof. Garegnani has nothing to disclose.
Boateng N. Asiedu Boakye	Mr. Asiedu Boakye has nothing to disclose.
Diego Ivaldi, PT	Mr. Ivaldi has nothing to disclose.
Roc Reguant, PhD	Dr. Reguant has received personal compensation for serving as an employee of Alexion.
Musambo M. Kapapa Jalloh, PT	Mrs. Kapapa Jalloh has nothing to disclose.
William Hind, PhD	Dr. Hind has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Hind has stock in Jazz Pharmaceuticals. Dr. Hind has received intellectual property interests from a discovery or technology relating to health care.
Daisy Liu	Miss Liu has received personal compensation for serving as an employee of Analysis Group.
Gabriel Otero-Duran	Mr. Otero-Duran has nothing to disclose.
Alyssa A. Do, BS	Ms. Do has nothing to disclose.
Marie Gurrola	Mrs. Gurrola has nothing to disclose.
Rajat Kalra, MBChB, MS	The institution of Dr. Kalra has received research support from American Heart Association. The institution of Dr. Kalra has received research support from National Heart, Lung, and Blood Institute/NIH.
Guoyun Yu, PhD	Dr. Yu has nothing to disclose.
Denzel Nketia-Achiampong	Mr. Nketia-Achiampong has nothing to disclose.
Olumide Arigbede, DrPH, MPH	Dr. Arigbede has nothing to disclose.
Firas Hentati, MD	Dr. Hentati has nothing to disclose.
Hussam Alhathlol, MBBS	Dr. Alhathlol has nothing to disclose.
Kevna Konduru	Ms. Konduru has nothing to disclose.
Rajvi J. Wani, PhD	Dr. Wani has nothing to disclose.
Andrea Meyers, DrPH	Dr. Meyers has received personal compensation for serving as an employee of Amgen. Dr. Meyers has stock in Amgen.
John N. Sewornu	Mr. Sewornu has nothing to disclose.
David J. Virley, PhD	Dr. Virley has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Dr. Virley has stock in Jazz Pharmaceuticals . Dr. Virley has received intellectual property interests from a discovery or technology relating to health care.
Erika Nnodi	Miss Nnodi has nothing to disclose.
Maurice PTITO, PhD	Prof. PTITO has nothing to disclose.
Muhammet B. Muş, Sr., MD	Dr. Mus has nothing to disclose.
Kristine Krug, DPhil	The institution of Prof. Krug has received research support from Deutsche Forschungsgemeinschaft. The institution of Prof. Krug has received research support from Leibniz Foundation. The institution of Prof. Krug has received research support from German Federal Ministry of Research, Technology & Space.
Harshvi N. Jobanputra, MD	Dr. Jobanputra has nothing to disclose.
Laura Pilati, MD	Dr. Pilati has nothing to disclose.
H S. White, PhD	Prof. White has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Prof. White has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharm. The institution of Prof. White has received research support from NIH. The institution of Prof. White has received research support from Neurelis.
Gina Forchelli, PhD	Dr. Forchelli has nothing to disclose.
William Hopkins, PhD	The institution of Dr. Hopkins has received research support from NIH.
Jeffrey Gilligan, MD	Dr. Gilligan has nothing to disclose.
Christopher S. Ahuja, MD, PhD	Dr. Ahuja has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Depuy SYnthes. Dr. Ahuja has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KurosBio. Dr. Ahuja has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SRI. Dr. Ahuja has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inteligex. Dr. Ahuja has stock in Inteligex. Dr. Ahuja has received intellectual property interests from a discovery or technology relating to health care. Dr. Ahuja has received intellectual property interests from a discovery or technology relating to health care.
Tugcan Korak, PhD	Dr. Korak has nothing to disclose.
Gurler Akpinar, PhD	Prof. Akpinar has nothing to disclose.
Rita R. Horvath, MD, PhD	Prof. Horvath has nothing to disclose.
Hafiz Muhammad Usama Javed, MBBS	Dr. Javed has nothing to disclose.
Nicolas Meza, MD	Mr. Meza has nothing to disclose.
Vidyulata Kamath, PhD	The institution of Dr. Kamath has received research support from NIH.
Lorenzo Carnevale, PhD	Prof. Carnevale has nothing to disclose.
Mark Solomon	Mr. Solomon has nothing to disclose.
Sree L. Venigalla, PhD	Dr. Venigalla has nothing to disclose.
Saara Ahmad Muddasir Khan, PhD	Dr. Khan has nothing to disclose.
Tomas Aquino, PhD	Dr. Aquino has received intellectual property interests from a discovery or technology relating to health care.
Franco Giulianini	Dr. Giulianini has nothing to disclose.
Paul M. Ridker, MD	Dr. Ridker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ridker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Ridker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agepha. Dr. Ridker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ridker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for New Amsterdam. Dr. Ridker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nodthera. Dr. Ridker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tourmaline Bio. Dr. Ridker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cardio Therapeitics. Dr. Ridker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LeDucq :Foundation. The institution of Dr. Ridker has received research support from Novo Nordisk Foundation. Dr. Ridker has received intellectual property interests from a discovery or technology relating to health care.
Riane Richard	Miss Richard has nothing to disclose.
Ali Mirza, PhD	Dr. Mirza has nothing to disclose.
Michal Bar, MD, PhD	Prof. Bar has nothing to disclose.
Ling Chen	Dr. Chen has nothing to disclose.
DEEPAK KHATRI, MD	Dr. KHATRI has nothing to disclose.
Ashutosh Mahapatra, MD	Dr. Mahapatra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scientia Neurovascular. Dr. Mahapatra has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra, Inc.. Dr. Mahapatra has stock in Gravity Medical Technology, Inc..
Richard Zampolin, MD	Dr. Zampolin has nothing to disclose.
FENG ZHU, MSc	Mr. ZHU has nothing to disclose.
Beni Turner	Mrs. Turner has nothing to disclose.
Rosheen Jamil, MD	Dr. Jamil has nothing to disclose.
Justin Chou, PhD	Dr. Chou has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Chou has received intellectual property interests from a discovery or technology relating to health care.
Maxwell E. Shramuk, MS	Mr. Shramuk has nothing to disclose.
Aimee R. Itaaehau, PharmD	Dr. Itaaehau has nothing to disclose.
Shelley Noland, MD	Dr. Noland has nothing to disclose.
Mark Rushek	Mr. Rushek has nothing to disclose.
Negar Heidarpour Bardei, DO	No disclosure on file
Kai Akimoto	Mr. Akimoto has nothing to disclose.
Jeremy Markowitz	Dr. Markowitz has nothing to disclose.
Colin Sweeney, PhD	Dr. Sweeney has nothing to disclose.
Timothy Hutson, PhD	Dr. Hutson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EpiFocus LLC. Dr. Hutson has received research support from Barrow Neurological Foundation.
Jill Hollenbach, PhD	Prof. Hollenbach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HLA journal.
Kevin Lei, BS	Mr. Lei has nothing to disclose.
Kristen J. Wade, PhD	Dr. Wade has nothing to disclose.
Regina M. Graham, PhD	The institution of Dr. Graham has received research support from HCA Florida University Hospital.
Matthew Nguyen	Mr. Nguyen has nothing to disclose.
Harmain N. Shaikh, MBBS	Dr. Shaikh has nothing to disclose.
Jikai Zhang	Mr. Zhang has nothing to disclose.
William G. Coon, PhD	Dr. Coon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Labs.
Anisha Dua, MD	Dr. Dua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Dua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Dua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for abbvie.
Jared Taylor	Mr. Taylor has nothing to disclose.
Mirvari Nasirova, Jr., MD	Miss Nasirova has nothing to disclose.
Rachel Stancl, MPA, BS	Ms. Stancl has nothing to disclose.
Mohamed Abo-elsoad, Medical student	Dr. Abo-elsoad has nothing to disclose.
Mahan Moshir, MSc	Mr. Moshir has received personal compensation for serving as an employee of argenx BV.
Ornella Binazon	Dr. Binazon has received personal compensation for serving as an employee of argenx. Dr. Binazon has stock in argenx.
Zhengxing Huang, PhD	Mr. Huang has nothing to disclose.
José Alberto Ávila Funes	No disclosure on file
Zhibing Ai	No disclosure on file
Sarah Caughlin	No disclosure on file
Anqi Cheng	No disclosure on file
Rahsan Gocmen	No disclosure on file
Jocelyn Hoye	No disclosure on file
Umut Kalyoncu	No disclosure on file
Zeynep Karakus	No disclosure on file
Jordan Larson	No disclosure on file
Linwen Liu	No disclosure on file
Ningyuan Liu	No disclosure on file
Yacouba Njankouo Mapoure	No disclosure on file
Diana Matallana	No disclosure on file
Hideki Oi	No disclosure on file
Caroline Pantazis	No disclosure on file
brian pittman	No disclosure on file
Amey Savardekar	No disclosure on file
Rene Silva Somoza	No disclosure on file
Fırat Sirvan	No disclosure on file
Weihai Xu	No disclosure on file
Weizhuang Yuan	No disclosure on file
Mingqiang Zheng	No disclosure on file
Mingli Li	No disclosure on file
Samer hamed Mohamed Hamed Amer Salama, MD, PhD	Dr. Salama has nothing to disclose.
YuPing Wang, PhD	The institution of Dr. Wang has received research support from National Science Fundation of China .
Paul Streck	No disclosure on file
Alberto Aleman, MD	No disclosure on file
Aayma Irfan, Medical Student	Ms. Irfan has nothing to disclose.
Shaoxia Yu, MS	No disclosure on file
Timothy C. Rogier, N/A	Mr. Rogier has received personal compensation for serving as an employee of Latigo Biotherapeutics. Mr. Rogier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Latigo Biotherapeutics. Mr. Rogier has received personal compensation in the range of $0-$499 for serving as a Consultant for Evolution Research Group.
Rui Zhang, MD	Mrs. Zhang has received personal compensation for serving as an employee of Hansoh Pharma.
Ran Liu	Ms. Liu has received personal compensation for serving as an employee of Hansoh Pharma.
Lu Yu	Dr. Yu has received personal compensation for serving as an employee of Hansoh Pharma.
Xia Liu	Prof. Liu has nothing to disclose.
Jian Wang	Prof. Wang has nothing to disclose.
Xianxiang Zeng	Prof. Zeng has nothing to disclose.
Haihang Yu	Prof. Yu has nothing to disclose.
Shize Li	Prof. Li has nothing to disclose.
Shiyou Tang	Prof. Tang has nothing to disclose.
Zhaoyang Huang	Prof. Huang has nothing to disclose.
Bo Zhou	Prof. Zhou has nothing to disclose.
Hanqiao Wang	Prof. Wang has nothing to disclose.
Qiaorong Xu	Prof. Xu has nothing to disclose.
Daomin Zhu	Prof. Zhu has nothing to disclose.
Xiaoqing Zhang	Dr. Zhang has received personal compensation for serving as an employee of Shanghai Hansoh BioMedical Co..
Bin Zhang	Prof. Zhang has nothing to disclose.
Qinying Ma	Prof. Ma has nothing to disclose.
Neil Singla, MD	Dr. Singla has received personal compensation for serving as an employee of Latigo Biotherapeutics. Dr. Singla has received personal compensation for serving as an employee of Evolution Research Group. Dr. Singla has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Singla has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tris Pharma. Dr. Singla has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Becton Dickinson. Dr. Singla has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Evolution Research Group. Dr. Singla has or had stock in Evolution Research Group. An immediate family member of Dr. Singla has or had stock in The Marigold Center (Private Practice).
Todd Bertoch, MD	Dr. Bertoch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Bertoch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex.
Ben Vaughn	Mr. Vaughn has received personal compensation for serving as an employee of Latigo. Mr. Vaughn has received personal compensation for serving as an employee of Rho, Inc. An immediate family member of Mr. Vaughn has received personal compensation for serving as an employee of RTI Health Solutions. Mr. Vaughn has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Altreos Research Partners. Mr. Vaughn has or had stock in Latigo.
Mallory Loflin, PhD	Dr. Loflin has received personal compensation for serving as an employee of Latigo Biotherapeutics, Inc. .
Ann J. Barbier, MD, PhD	No disclosure on file
Harold Minkowitz, MD	Dr. Minkowitz has nothing to disclose.
Anne Sophie Rolland, PhD	Dr. Rolland has nothing to disclose.
Brijesh Garg	No disclosure on file
Gregory Song	No disclosure on file
Pallavi Lonkar	No disclosure on file
Sarah Vacca	No disclosure on file
Stephen Babcock	No disclosure on file
Sejal Batra	No disclosure on file
Assia Zanat, MD	Dr. Zanat has nothing to disclose.
Steven Vanni, DO	Dr. Vanni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xtant. Dr. Vanni has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Attorneys . Dr. Vanni has received intellectual property interests from a discovery or technology relating to health care.
Alena Khalil	Ms. Khalil has nothing to disclose.
Vito G. Evola, Medical Student	Mr. Evola has nothing to disclose.
Joshua Costin, PhD	Prof. Costin has nothing to disclose.
Samiksha Prasad, PhD	Dr. Prasad has nothing to disclose.
Abdullah Serhan, MD	Dr. Serhan has nothing to disclose.
Samar Shehata	Ms. Shehata has nothing to disclose.
Jordan H. Larson, MD	No disclosure on file
Jessica Hunt, PharmD	Dr. Hunt has nothing to disclose.